Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3022756	s-kerulo	mg/l (mg/l)	2003	2124	0.00%
3022756	s-kerulo	g/l (mg/l)	1392	1468	0.00%
3022756	s-kerulo	— (—)	349	382	100.00%	Distribution not available
3022756	s-kerulo	mg/l______ (mg/l)	48	50	0.00%
3022756	s-kerulo	mg/L (mg/l)	6	6	0.00%	Distribution not available
3022756	s-kerulo	MG/L (mg/l)	6	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic hepatitis, not elsewhere classified

188

45.19

313.48

1.1

1.0

284.31

294.33

mg/l

0.44

169

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

779

347

25.33

307.65

1.1

1.0

289.65

283.42

mg/l

0.72

714

313

Other diseases of liver

985

324

34.14

307.65

1.1

1.0

292.24

287.55

mg/l

0.46

880

303

Oesophageal varices

246

116

24.76

307.65

1.1

286.32

285.14

mg/l

0.05

228

105

Diseases of liver

1829

634

32.03

307.65

1.1

1.0

292.47

283.62

mg/l

2.05

1652

584

Abnormal findings on examination of blood, without diagnosis

846

1340

5.87

307.65

1.1

294.08

281.62

mg/l

3.82

793

1208

Nonalcoholic fatty liver disease

687

313

25.71

307.65

1.1

1.0

285.62

290.71

mg/l

0.48

619

287

Fibrosis and cirrhosis of liver

546

116

56.32

307.65

1.1

1.0

294.71

292.24

mg/l

0.13

498

107

Abnormal serum enzyme levels

680

865

7.90

307.65

1.1

293.85

279.95

mg/l

3.44

645

781

Alcoholic liver disease

401

152

28.95

307.65

1.1

1.0

284.26

281.76

mg/l

0.14

363

140

Cirrhosis of liver, NAS

427

115

45.86

307.65

1.1

1.0

289.42

288.92

mg/l

0.02

393

103

Ascites

258

181

15.36

288.46

1.1

1.0

297.78

291.77

mg/l

0.35

236

164

GASTRO-related operations

824

845

4.95

282.85

1.1

287.03

628.12

mg/l

0.50

755

777

Any gastric operation

824

845

4.95

282.85

1.1

287.03

628.12

mg/l

0.50

755

777

Other inflammatory liver diseases

202

111

19.55

255.58

1.1

1.0

299.78

287.71

mg/l

0.82

193

102

Autoimmune hepatitis, wide definition

187

119

17.24

220.88

1.1

298.27

289.92

mg/l

0.49

179

110

Hepatic failure, not elsewhere classified

139

31.81

211.39

1.1

1.0

293.91

291.07

mg/l

0.08

130

Gastrointestinal diseases

545

502

5.50

207.52

1.1

288.39

845.78

mg/l

0.49

500

474

Alcohol use disorder, Swedish definition

651

1792

3.35

168.66

1.1

284.32

283.87

mg/l

0.05

589

1647

Abnormal results of function studies

227

297

8.04

163.87

1.2

1.1

295.27

288.26

mg/l

0.51

190

268

670

1896

3.20

160.49

1.1

284.80

282.89

mg/l

0.24

606

1742

Primary biliary cholangitis, wide definition

112

24.40

153.47

1.1

317.51

292.61

mg/l

1.82

683

1959

3.07

151.94

1.1

285.03

283.42

mg/l

0.20

618

1800

Anaemias

280

308

5.92

128.80

1.1

297.51

284.18

mg/l

1.30

258

292

Diseases of oesophagus, stomach and duodenum

992

2433

2.43

127.80

1.1

286.98

409.00

mg/l

0.52

891

2253

Autoimmune diseases excluding thyroid diseases

963

2138

2.46

124.57

1.1

289.60

420.41

mg/l

0.48

882

1973

Extrapyramidal and movement disorders

427

1230

3.53

123.05

1.1

278.98

292.47

mg/l

3.28

392

1110

Autoimmune diseases excluding thyroid diseases, strict definition

930

2082

2.45

119.30

1.1

289.01

423.79

mg/l

0.48

852

1920

Primary biliary cholangitis (PBC)

20.39

114.79

1.1

323.63

300.60

mg/l

1.38

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

897

2579

2.36

113.19

1.1

296.97

400.24

mg/l

0.45

823

2365

Autoimmune diseases related-to ILD

810

2832

2.41

112.19

1.1

292.24

391.12

mg/l

0.47

741

2590

Disorders of gallbladder, biliary tract and pancreas

881

2355

2.35

107.25

1.1

293.28

413.15

mg/l

0.48

810

2146

ILD medications: immunosuppressive drugs

641

2267

2.59

105.00

1.1

290.32

415.90

mg/l

0.48

605

2072

Autoimmune diseases

962

2150

2.29

104.44

1.1

285.69

419.91

mg/l

0.50

875

1985

Primary Sclerosing Cholangitis, IBD and UDCA required

16.30

102.91

1.1

309.16

267.75

mg/l

3.12

Inflammatory bowel disease treatment related agents

996

2557

2.17

98.77

1.1

290.09

402.11

mg/l

0.49

923

2330

Type 2 diabetes, wide definition

679

1726

2.50

95.18

1.1

289.47

458.48

mg/l

0.50

603

1585

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

609

2110

2.53

95.02

1.1

1.0

293.95

427.69

mg/l

0.47

550

1915

ILD medications

972

2435

2.17

94.66

1.1

289.45

407.39

mg/l

0.49

898

2222

Endocrine, nutritional and metabolic diseases

688

1377

2.54

93.17

1.1

286.44

495.15

mg/l

0.50

632

1285

Examination and observation for other reasons

512

996

2.92

92.98

1.1

298.14

285.18

mg/l

2.37

487

917

Heart failure, not strict

647

1771

2.48

90.44

1.1

301.01

448.71

mg/l

0.43

587

1605

Hernia of abdominal wall, postoperative

162

276

5.91

89.67

1.1

1.0

292.90

283.86

mg/l

0.68

149

244

Medical observation and evaluation for suspected diseases and conditions

545

999

2.81

89.36

1.1

282.72

284.96

mg/l

0.26

487

920

Cholangitis (primary sclerosing, PSC)

123

160

8.00

89.17

1.1

307.27

289.38

mg/l

1.11

113

140

Used for control exclusion in common control thyroid runs

876

2001

2.22

89.04

1.1

284.43

429.05

mg/l

0.50

795

1845

Budesonide

208

465

4.58

85.70

1.1

290.46

287.53

mg/l

0.18

190

428

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

786

2418

2.21

85.30

1.1

289.62

406.78

mg/l

0.48

717

2212

Substance abuse, excluding more controls

522

1695

2.60

84.95

1.1

289.13

286.31

mg/l

0.36

467

1569

Type 2 diabetes

822

2179

2.20

84.78

1.1

287.40

424.67

mg/l

0.52

744

2001

Condition for Implicit Sepsis (Organ dysfunction codes)

739

2289

2.25

84.52

1.1

290.83

413.22

mg/l

0.47

675

2091

First line medication for Crohn's disease

930

2395

2.10

84.20

1.1

287.24

410.01

mg/l

0.50

858

2183

ILD medications: prednisolone, methylprednisolone, prednisone

904

2388

2.12

84.12

1.1

288.54

409.84

mg/l

0.49

830

2179

Implicit bacterial Sepsis

376

1060

3.07

84.04

1.1

302.65

285.14

mg/l

3.33

341

961

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

794

2145

2.21

83.56

1.1

288.13

425.11

mg/l

0.51

719

1975

Acute renal failure

235

589

4.06

83.16

1.1

304.54

282.45

mg/l

3.66

221

527

Implicit bacterial Sepsis, including avohilmo

402

1155

2.92

81.80

1.1

301.37

284.19

mg/l

3.49

367

1050

Tramadol

693

1810

2.32

81.73

1.1

294.25

448.93

mg/l

0.48

629

1664

Anxiety disorders, excluding more controls

718

2045

2.26

81.09

1.1

292.04

289.60

mg/l

0.35

650

1884

Hepatocellular carcinoma, including Hilmo

11.98

80.23

1.0

278.56

285.73

mg/l

0.25

Diabetes, varying definitions

845

2323

2.12

80.05

1.1

287.73

414.70

mg/l

0.51

762

2141

Diabetes mellitus

847

2323

2.12

79.83

1.1

287.91

414.72

mg/l

0.51

765

2140

Implicit Sepsis

647

2079

2.31

79.63

1.1

295.64

285.57

mg/l

2.26

592

1893

Implicit Sepsis, including avohilmo

703

2263

2.23

79.57

1.1

292.71

414.93

mg/l

0.46

644

2061

Symptoms and signs involving the nervous and musculoskeletal systems

526

2172

2.44

78.32

1.1

281.43

292.34

mg/l

2.91

506

1963

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

289

369

3.96

78.09

1.1

283.68

284.20

mg/l

0.03

266

347

Symptoms and signs involving the digestive system and abdomen

788

1820

2.18

76.86

1.1

286.58

286.04

mg/l

0.06

718

1682

Type 2 diabetes, strict (exclude DM1)

773

2095

2.16

76.68

1.1

287.07

430.32

mg/l

0.52

701

1926

Metabolic disorders

798

2266

2.13

76.66

1.1

290.95

418.01

mg/l

0.49

732

2069

Bacterial Sepsis

407

1215

2.79

76.28

1.1

302.74

283.99

mg/l

4.09

370

1106

Renal failure

401

1229

2.81

76.23

1.1

301.84

285.68

mg/l

3.56

374

1100

Dipeptidyl peptidase 4 (DPP-4) inhibitors

447

1321

2.68

76.19

1.1

1.0

280.81

290.40

mg/l

1.77

397

1200

Type 2 diabetes, definitions combined

768

2083

2.16

76.04

1.1

286.70

431.50

mg/l

0.53

696

1914

Noninfective enteritis and colitis

461

1818

2.56

75.68

1.1

284.44

287.47

mg/l

0.36

426

1660

Diabetes, insulin treatment (Kela reimbursement)

825

2365

2.09

75.61

1.1

286.91

413.13

mg/l

0.52

749

2169

Nutritional anaemias

428

1559

2.64

74.34

1.1

303.65

292.23

mg/l

2.13

381

1420

Other (not insulin) diabetes medications

790

2210

2.11

74.15

1.1

284.50

423.53

mg/l

0.54

714

2030

Any reimbursement code in KELA

497

940

2.67

74.00

1.1

285.94

284.95

mg/l

0.09

455

872

Inflammatory bowel disease

352

1231

2.90

73.51

1.1

284.56

285.97

mg/l

0.12

326

1128

Diseases of the digestive system

409

1532

2.68

73.49

1.1

289.53

288.06

mg/l

0.13

373

1389

5-aminosalicylic acid

258

752

3.49

73.36

1.1

284.20

285.03

mg/l

0.06

235

690

Iron deficiency anaemia

385

1382

2.76

73.30

1.1

305.72

292.07

mg/l

2.60

344

1254

Type 2 diabetes, definitions combined, including avohilmo

763

2081

2.13

73.24

1.1

287.30

431.12

mg/l

0.52

695

1911

Insulin medication

500

1701

2.46

72.69

1.1

295.93

286.77

mg/l

1.73

444

1566

Diabetes medication

845

2432

2.04

72.63

1.1

288.19

409.45

mg/l

0.51

763

2242

Anxiety disorders

788

2635

2.06

72.55

1.1

292.41

398.19

mg/l

0.47

716

2419

Neurotic, stress-related and somatoform disorders

781

2630

2.06

71.43

1.1

292.11

398.45

mg/l

0.48

710

2414

General symptoms and signs

857

2109

2.05

71.27

1.1

288.74

425.24

mg/l

0.49

788

1924

Mood disorders, excluding more controls

757

2127

2.10

70.57

1.1

675.48

290.37

mg/l

0.50

687

1960

Dystonia

113

176

6.70

69.73

1.1

1.0

283.17

290.13

mg/l

0.37

104

159

Other disorders of fluid, electrolyte and acid-base balance

281

831

3.22

69.68

1.0

1.1

294.18

289.75

mg/l

0.30

250

750

Aplastic and other anaemias

381

1295

2.72

69.39

1.1

293.91

290.34

mg/l

0.37

347

1167

Other and unspecified anaemias

356

1202

2.81

69.37

1.1

295.95

290.46

mg/l

0.66

323

1084

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

126

7.93

69.13

1.0

280.09

283.68

mg/l

0.13

113

Other anaemias

357

1214

2.78

68.21

1.1

295.72

290.41

mg/l

0.64

324

1096

Anxiety (asthma-related co-morbidities)

563

1889

2.28

68.08

1.1

292.04

288.62

mg/l

0.46

515

1741

Other nutritional deficiencies

604

2548

2.18

67.99

1.1

292.25

402.62

mg/l

0.49

533

2360

Gastro-oesophageal reflux disease

565

2128

2.26

67.97

1.1

286.10

426.38

mg/l

0.53

491

1971

Other extrapyramidal and movement disorders in other diseases

259

796

3.30

67.71

1.1

279.14

290.86

mg/l

1.81

239

723

Oral corticosteroids

836

2472

1.99

67.55

1.1

289.90

406.23

mg/l

0.49

769

2250

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

412

969

2.70

67.53

1.1

293.16

290.82

mg/l

0.20

377

901

Unspecified jaundice

107

8.52

67.47

1.1

1.0

314.46

287.52

mg/l

1.41

GI-bleeding

280

905

3.13

67.14

1.1

1.0

296.25

285.61

mg/l

1.34

256

825

Cholelithiasis, broad definition with cholecystitis

678

2135

2.13

67.01

1.1

293.46

427.76

mg/l

0.49

626

1946

Cholelithiasis

655

2094

2.15

66.81

1.1

292.61

431.21

mg/l

0.49

604

1906

Other diseases of the digestive system

281

913

3.11

66.81

1.1

1.0

295.75

285.96

mg/l

1.23

258

835

Chronic gastritis

230

666

3.50

65.98

1.1

289.12

293.92

mg/l

0.37

193

606

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

105

162

6.69

65.21

1.1

1.0

283.93

286.32

mg/l

0.09

146

IBD patients in KELA-register

278

916

3.08

64.73

1.1

282.77

285.04

mg/l

0.19

257

845

Substance abuse

522

2164

2.26

64.24

1.1

289.13

282.07

mg/l

1.36

467

1995

Inflammatory bowel disease, strict (require KELA)

278

921

3.07

64.13

1.1

282.77

285.50

mg/l

0.24

257

846

Depression

799

2735

1.96

63.94

1.1

653.78

288.48

mg/l

0.50

729

2509

Mood [affective] disorders

836

2781

1.94

63.55

1.1

639.63

288.78

mg/l

0.50

761

2553

Mental and behavioural disorders due to psychoactive substance use

532

2202

2.23

63.33

1.1

289.34

282.25

mg/l

1.39

477

2028

Other gastritis (incl. Duodenitis)

214

613

3.54

62.52

1.1

1.0

287.32

289.06

mg/l

0.12

192

562

Mood disorders

834

2785

1.93

62.36

1.1

640.57

288.73

mg/l

0.50

759

2557

Insulin, intermediate and long-acting

463

1930

2.33

61.98

1.1

296.81

283.42

mg/l

3.06

413

1766

Depression medications

256

362

3.59

61.01

1.1

287.97

278.00

mg/l

0.86

233

340

Biguanides

740

2246

2.00

60.88

1.1

284.80

422.75

mg/l

0.55

671

2063

Mental and behavioural disorders due to alcohol, excluding acute intoxication

409

1681

2.44

60.50

1.1

284.11

281.67

mg/l

0.26

365

1552

Cholangitis (primary sclerosing, PSC), with reimbursement 202

12.21

60.27

1.1

309.74

286.85

mg/l

0.94

Obesity and other hyperalimentation

560

2486

2.13

60.00

1.1

292.93

405.31

mg/l

0.48

491

2302

Other septicaemia, including avohilmo

319

1106

2.73

59.19

1.1

303.83

285.67

mg/l

2.76

290

1002

Insulin, combination of fast acting with intermediate-acting or long-acting

500

2053

2.22

59.16

1.1

295.93

284.40

mg/l

2.57

444

1878

Obesity

555

2479

2.12

58.78

1.1

293.34

405.53

mg/l

0.48

486

2295

General examination and investigation of persons without complaint and reported diagnosis

464

999

2.43

58.17

1.1

288.95

284.96

mg/l

0.47

426

920

Spasmodic torticollis

8.70

57.85

1.1

276.09

288.60

mg/l

0.57

Explicit Sepsis, including avohilmo

362

1302

2.54

57.72

1.1

303.64

286.39

mg/l

2.91

328

1181

Other and unspecified iron deficiency

300

1094

2.77

57.70

1.1

1.0

309.69

291.17

mg/l

3.59

269

991

Antihypertensive medication - note that there are other indications

501

1132

2.33

57.55

1.1

288.77

286.09

mg/l

0.25

462

1050

ILD medications: azathioprine

181

492

3.75

57.36

1.1

284.41

287.09

mg/l

0.17

168

454

Alcohol use disorder, ICD-based

380

1565

2.45

57.24

1.1

285.01

281.45

mg/l

0.42

339

1438

Hypertensive diseases (excluding secondary)

452

1105

2.40

57.11

1.1

288.06

288.17

mg/l

0.01

406

1025

Mental and behavioural disorders due to alcohol

448

1882

2.29

57.07

1.1

285.80

281.58

mg/l

0.58

402

1733

Other septicaemia

310

1087

2.71

56.87

1.1

304.23

285.16

mg/l

2.89

283

984

Ulcerative colitis

269

937

2.91

56.77

1.1

283.01

286.05

mg/l

0.25

247

858

All anxiety disorders

568

2109

2.10

56.67

1.1

292.19

286.62

mg/l

0.92

520

1941

Explicit Sepsis

352

1267

2.55

56.66

1.1

303.91

286.55

mg/l

2.83

320

1148

Other bacterial diseases, including avohilmo

801

2657

1.89

56.63

1.1

298.37

394.76

mg/l

0.42

735

2431

Continuous positive airway pressure

160

321

4.20

56.54

1.0

1.1

282.88

285.53

mg/l

0.17

137

310

Azathioprine

181

499

3.69

56.19

1.1

284.41

286.06

mg/l

0.10

168

459

Fever of other and unknown origin

456

1753

2.27

56.11

1.1

299.49

287.53

mg/l

2.02

426

1600

Other diseases of intestines

827

2473

1.87

55.19

1.1

288.44

404.30

mg/l

0.50

751

2290

Reimbursement for rheumatic diseases

472

2164

2.18

54.34

1.1

293.75

427.38

mg/l

0.49

438

1958

Hypothyroidism (congenital or acquired)

212

329

3.64

53.87

1.1

291.03

281.41

mg/l

0.75

186

311

Malaise and fatigue

414

1400

2.34

53.85

1.1

293.99

287.62

mg/l

0.72

384

1259

Septicaemia

338

1225

2.54

53.81

1.1

304.08

285.43

mg/l

3.06

306

1109

Other bacterial diseases

736

2581

1.90

53.36

1.1

299.87

398.53

mg/l

0.42

673

2358

Hypothyroidism and >3 levothyroxin purchases

209

326

3.62

52.85

1.1

291.71

282.18

mg/l

0.73

184

308

Hypothyroidism, levothyroxine purchases

209

326

3.62

52.85

1.1

291.71

282.18

mg/l

0.73

184

308

Persons encountering health services for other counselling and medical advice, not elsewhere classified

839

2435

1.84

52.46

1.1

289.22

409.12

mg/l

0.50

779

2214

Cardiovascular diseases (excluding rheumatic etc)

532

1424

2.15

52.25

1.1

290.44

286.90

mg/l

0.39

490

1326

Second line medication for Crohn's disease

498

2381

2.11

52.23

1.1

286.59

411.85

mg/l

0.51

469

2170

Chronic kidney disease

236

766

2.99

52.17

1.1

1.0

300.13

284.98

mg/l

1.87

217

689

Other antidepressants

754

2031

1.90

51.85

1.1

287.28

429.94

mg/l

0.50

685

1880

Obesity due to excess calories

426

1926

2.23

51.74

1.1

292.63

290.72

mg/l

0.21

377

1782

Heart failure and antihypertensive medication

198

365

3.56

51.49

1.0

1.1

306.76

287.19

mg/l

2.55

180

330

Neurological diseases

644

1619

2.01

51.19

1.1

284.17

291.60

mg/l

1.46

588

1492

Glucagon-like peptide-1 (GLP-1) analogues

289

1104

2.65

51.10

1.1

1.0

287.45

288.60

mg/l

0.10

258

1013

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

289

1104

2.65

51.10

1.1

1.0

287.45

288.60

mg/l

0.10

258

1013

Nausea and vomiting

227

742

3.01

50.95

1.1

294.56

287.39

mg/l

0.62

206

680

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

200

634

3.21

49.94

1.1

278.99

284.95

mg/l

0.53

182

584

Ulcerative colitis (strict definition, require KELA)

203

650

3.18

49.83

1.1

280.55

284.67

mg/l

0.33

185

597

117

259

4.63

49.05

1.1

283.76

282.30

mg/l

0.05

105

239

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

212

705

3.06

48.77

1.1

279.61

284.37

mg/l

0.41

193

648

All kidney diseases

748

2749

1.83

48.75

1.1

294.60

394.96

mg/l

0.46

693

2510

Any mental disorder

785

2144

1.84

48.65

1.1

285.98

290.43

mg/l

0.78

710

1973

Renal tubulo-interstitial diseases

658

2560

1.89

48.40

1.1

298.22

403.62

mg/l

0.45

613

2328

Infections, IBD-co-morbidities

143

242

4.20

47.71

1.1

286.20

285.99

mg/l

0.01

130

227

Other special examinations and investigations of persons without complaint or reported diagnosis

444

999

2.26

47.67

1.1

282.46

284.96

mg/l

0.24

411

920

Abdominal and pelvic pain

689

1820

1.91

47.66

1.1

286.24

286.04

mg/l

0.02

632

1682

Ulcerative colitis, NAS

170

504

3.44

47.35

1.1

279.84

284.76

mg/l

0.33

157

466

Hypertension, essential

603

1740

1.97

46.98

1.1

285.25

454.85

mg/l

0.51

540

1605

Abnormalities of breathing

681

2075

1.89

46.97

1.1

289.65

427.84

mg/l

0.49

624

1911

Opioids

725

2021

1.86

46.79

1.1

288.52

429.76

mg/l

0.49

668

1862

Neurological diseases, wide definition

241

396

3.08

46.14

1.1

292.56

287.48

mg/l

0.34

219

378

Selective serotonin reuptake inhibitors

723

2040

1.85

45.98

1.1

284.38

429.27

mg/l

0.52

647

1889

Ulcerative colitis (strict definition, all Crohn cases excluded)

172

528

3.32

45.33

1.1

281.39

284.28

mg/l

0.18

158

486

Persons encountering health services in other circumstances, wide

832

2435

1.76

45.19

1.1

285.93

409.12

mg/l

0.52

768

2214

Cholecystectomy

525

2292

1.96

43.88

1.1

292.81

422.35

mg/l

0.51

484

2077

Certain infectious and parasitic diseases

701

1917

1.84

43.40

1.1

293.10

436.42

mg/l

0.46

644

1758

Bleeding

611

2299

1.87

43.22

1.1

297.87

412.61

mg/l

0.44

556

2098

Malignant neoplasm of liver and intrahepatic bile ducts

8.16

42.83

1.0

283.69

284.01

mg/l

0.01

Hypertension

599

1780

1.91

42.63

1.1

286.88

450.54

mg/l

0.51

535

1643

6-mercaptopurine

114

6.47

42.59

1.1

270.77

287.31

mg/l

0.81

101

Hypertensive diseases

599

1781

1.91

42.58

1.1

286.88

450.63

mg/l

0.51

535

1644

Oedema, not elsewhere classified

254

972

2.57

42.45

1.1

293.27

289.95

mg/l

0.31

232

876

Cardiovascular diseases

487

1259

2.06

42.45

1.1

286.95

286.25

mg/l

0.05

446

1174

Mucosal proctocolitis

156

475

3.34

41.72

1.1

289.56

285.48

mg/l

0.26

142

439

Benzodiazepine use

743

2893

1.74

41.10

1.1

291.68

389.39

mg/l

0.48

668

2659

Persons encountering health services for examination and investigation

427

999

2.15

40.84

1.1

286.12

284.96

mg/l

0.10

391

920

Caries of dentine

208

724

2.80

40.84

1.0

290.94

283.81

mg/l

0.50

187

675

Depression or dysthymia

471

1260

2.05

40.79

1.1

284.13

289.83

mg/l

0.75

428

1169

Hypokalaemia

120

313

3.89

40.46

1.1

284.73

292.02

mg/l

0.39

106

285

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

700

2514

1.77

40.27

1.1

290.95

406.01

mg/l

0.50

640

2300

Heart failure,strict

349

1092

2.24

40.16

1.0

1.1

310.77

280.22

mg/l

10.53

324

983

Dental caries

227

814

2.66

40.14

1.1

291.09

286.69

mg/l

0.29

206

759

Other soft tissue disorders, not elsewhere classified

686

2198

1.78

39.69

1.1

290.88

289.25

mg/l

0.19

619

2027

Irritable bowel syndrome

240

953

2.54

39.32

1.1

286.82

294.42

mg/l

0.77

211

877

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

127

5.82

39.19

1.1

1.0

287.59

282.12

mg/l

0.19

115

Headache

490

1972

1.93

38.77

1.1

287.77

435.29

mg/l

0.50

454

1805

Low back pain

582

2148

1.84

38.60

1.1

291.61

425.34

mg/l

0.50

526

1979

Psychiatric diseases

672

1894

1.78

37.86

1.1

286.45

289.16

mg/l

0.37

615

1738

Implicit viral Sepsis, including avohilmo

226

891

2.55

37.38

1.1

293.70

286.62

mg/l

0.66

209

809

Codeine

650

1984

1.78

36.88

1.1

290.02

432.63

mg/l

0.49

597

1829

Viral hepatitis, including avohilmo

108

281

3.94

36.73

1.2

1.1

306.75

276.11

mg/l

2.38

102

256

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

736

2798

1.69

36.62

1.1

293.79

392.49

mg/l

0.47

675

2560

L04AX Other immunosuppressants

443

2311

1.93

36.61

1.1

288.21

289.51

mg/l

0.13

416

2108

Bacterial infection, other or unspecified, including avohilmo

410

1692

2.00

36.23

1.1

306.87

285.79

mg/l

4.68

374

1528

Diarrhoea and gastroenteritis of presumed infectious origin

524

2582

1.82

35.61

1.1

295.46

286.79

mg/l

1.73

489

2363

Pain in joint

428

1324

2.00

35.56

1.1

288.68

286.16

mg/l

0.26

384

1223

Other anxiety disorders

391

1673

2.00

35.03

1.1

290.97

286.96

mg/l

0.46

360

1540

Intestinal infectious diseases

685

3036

1.68

34.40

1.1

294.05

384.21

mg/l

0.46

635

2768

Symptoms and signs involving the circulatory and respiratory systems

707

2082

1.71

34.39

1.1

286.19

427.11

mg/l

0.51

642

1918

Recurrent or chronic depression

311

987

2.20

34.19

1.1

289.40

289.74

mg/l

0.02

276

920

Functional dyspepsia

214

865

2.50

33.85

1.1

291.57

293.23

mg/l

0.11

191

795

Bacterial infection, other or unspecified

369

1553

2.02

33.75

1.1

308.07

285.11

mg/l

4.76

334

1410

Symptoms and signs involving cognition, perception, emotional state and behaviour

692

2772

1.67

33.36

1.1

287.97

394.84

mg/l

0.51

624

2548

Constipation

629

2493

1.72

33.30

1.1

283.96

407.91

mg/l

0.55

555

2293

Follow-up examination after treatment for conditions other than malignant neoplasms

289

861

2.25

33.16

1.0

1.1

302.45

287.71

mg/l

2.87

262

789

Intestinal infectious diseases, including avohilmo, including avohilmo

803

2763

1.62

33.13

1.1

294.88

393.79

mg/l

0.46

736

2526

All chronic kidney diseases

385

1559

1.98

33.12

1.1

300.45

285.20

mg/l

3.20

357

1411

Lower back pain or/and sciatica

760

2898

1.64

33.03

1.1

289.18

389.88

mg/l

0.50

686

2660

Pain in throat and chest

597

2038

1.74

32.34

1.1

285.83

430.12

mg/l

0.51

542

1880

Hypothyroidism, strict autoimmune

466

1657

1.85

31.73

1.1

295.42

462.61

mg/l

0.47

411

1526

Iron deficiency anaemia secondary to blood loss (chronic)

136

453

3.04

31.34

1.1

1.0

297.68

288.57

mg/l

0.67

119

410

Other heart diseases

352

1136

2.03

30.93

1.0

1.1

295.03

288.60

mg/l

0.76

323

1057

Non-invasive ventilation

162

507

2.78

30.83

1.0

1.1

301.86

289.12

mg/l

0.96

142

488

Sleep apnoea

669

2553

1.66

30.79

1.1

288.68

402.92

mg/l

0.50

601

2349

Insulin, fast-acting

273

1276

2.15

30.74

1.1

305.40

281.76

mg/l

4.76

242

1172

Disorders of thyroid, IBD co-morbidities

126

260

3.34

30.72

1.0

302.00

294.10

mg/l

0.43

115

244

Other and unspecified polyneuropathies, also in other diseases

156

568

2.78

30.57

1.1

297.31

285.61

mg/l

1.04

147

517

Heart failure, strict

363

1282

1.98

30.36

1.0

1.1

310.33

281.95

mg/l

9.85

335

1148

Asthma, excluding more controls

510

1454

1.81

30.34

1.1

292.58

485.19

mg/l

0.48

466

1332

Disorders of lipoprotein metabolism and other lipidaemias

555

1945

1.74

30.34

1.1

292.11

438.58

mg/l

0.48

506

1775

Parkinson's disease, excluding more controls

102

265

3.58

30.02

1.0

1.1

272.99

297.71

mg/l

2.83

236

Other symptoms and signs involving the nervous and musculoskeletal systems

312

1550

2.03

29.90

1.1

277.64

292.46

mg/l

3.75

295

1398

L04AA Selective immunosuppressants

202

844

2.42

29.86

1.1

296.00

287.48

mg/l

0.75

194

763

Parkinson's disease, strict definition, excluding more controls

245

3.69

29.72

1.0

1.1

274.41

296.67

mg/l

2.34

220

Cardiac arrhythmias

417

1427

1.88

29.65

1.1

294.66

290.26

mg/l

0.46

379

1322

Polyneuropathies and other disorders of the peripheral nervous system

175

687

2.57

29.55

1.1

1.0

301.51

285.09

mg/l

1.86

165

626

Other reaction to severe stress, and adjustment disorders

295

1442

2.06

29.51

1.1

293.50

289.56

mg/l

0.32

266

1323

Dorsalgia

685

2220

1.64

29.19

1.1

286.61

419.96

mg/l

0.52

626

2046

Implicit viral Sepsis

156

583

2.70

29.06

1.1

297.36

285.40

mg/l

1.01

143

535

Viral Sepsis

156

583

2.70

29.06

1.1

297.36

285.40

mg/l

1.01

143

535

Unspecified kidney failure

235

3.80

28.81

1.1

1.0

294.83

284.32

mg/l

0.53

206

Sleep apnoea, including avohilmo

696

2614

1.62

28.74

1.1

288.20

400.12

mg/l

0.51

627

2401

Pain (limb, back, neck, head abdominally)

482

1345

1.80

28.31

1.0

1.1

285.49

285.63

mg/l

0.01

439

1244

Haemorrhage from respiratory passages

236

944

2.23

28.30

1.0

309.90

285.44

mg/l

4.74

213

854

Alcohol dependence

212

927

2.31

28.24

1.1

289.83

278.69

mg/l

1.27

192

852

Pain in limb

566

2136

1.69

28.11

1.1

296.24

289.64

mg/l

1.05

513

1970

Persons encountering health services in other circumstances

298

1475

2.01

27.98

1.1

285.99

288.85

mg/l

0.26

282

1346

All-cause Heart Failure

350

1259

1.94

27.90

1.0

1.1

310.01

282.06

mg/l

9.33

323

1129

Codeine or tramadol medication

763

2655

1.57

27.09

1.1

290.32

398.39

mg/l

0.49

698

2434

Asthma, unspecified (mode), excluding more controls

358

1352

1.90

27.05

1.1

293.06

501.62

mg/l

0.48

326

1238

Coagulation defects, purpura and other haemorrhagic conditions

165

658

2.53

27.01

1.1

1.0

290.40

288.31

mg/l

0.11

152

601

Insulin, fast-acting or short human

273

1342

2.05

26.98

1.1

305.40

281.44

mg/l

4.90

242

1227

Asthma

521

1560

1.73

26.82

1.1

292.57

473.19

mg/l

0.48

476

1428

Hypo-osmolality and hyponatraemia

127

442

2.88

26.68

1.1

299.33

292.00

mg/l

0.28

114

395

Persons encountering health services for specific procedures and health care

745

2824

1.56

26.63

1.1

294.29

389.88

mg/l

0.45

675

2590

Hypothyroidism, drug reimbursement

194

3.56

26.40

1.1

1.0

308.83

291.82

mg/l

1.14

185

Chronic laryngitis and laryngotracheitis

126

444

2.87

26.36

1.0

1.1

285.50

290.32

mg/l

0.29

103

407

Personality disorders, excluding more controls

201

883

2.29

26.35

1.1

292.17

288.63

mg/l

0.29

178

815

Benign neoplasm: Colon

352

1779

1.87

26.33

1.1

289.04

290.28

mg/l

0.12

310

1615

Pure hypercholesterolaemia

484

1781

1.73

26.31

1.1

291.89

452.37

mg/l

0.48

440

1618

Atrial fibrillation and flutter with reimbursement

169

414

2.59

26.02

1.1

1963.38

285.10

mg/l

0.50

160

378

Other symptoms and signs involving the digestive system and abdomen

132

480

2.78

26.00

1.0

1.1

297.68

293.02

mg/l

0.30

117

435

Other diseases of pancreas

220

3.74

25.97

1.1

285.90

288.65

mg/l

0.11

198

Asthma (only as main-diagnosis), excluding more controls

462

1454

1.76

25.91

1.1

293.02

485.19

mg/l

0.47

418

1332

Dyspnoea

606

2720

1.61

25.85

1.1

293.07

397.46

mg/l

0.48

555

2485

Crohn disease

131

477

2.78

25.81

1.1

286.50

285.03

mg/l

0.08

123

438

Systemic connective tissue disorders

246

1185

2.09

25.76

1.1

296.25

294.89

mg/l

0.11

227

1073

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

205

908

2.25

25.65

1.1

294.54

289.96

mg/l

0.34

184

835

Bipolar affective disorders

169

700

2.44

25.54

1.1

287.04

285.86

mg/l

0.07

157

652

Benign neoplasm of colon, rectum, anus and anal canal

409

1957

1.77

25.54

1.1

292.85

439.84

mg/l

0.49

359

1778

Intracranial trauma

383

1417

1.83

25.52

1.1

1023.10

291.54

mg/l

0.49

358

1310

Obesity, other/unspecified

264

1319

2.02

25.04

1.1

297.50

290.93

mg/l

0.72

234

1221

Diseases of arteries, arterioles and capillaries (FINNGEN)

159

428

2.58

24.93

1.1

297.27

283.35

mg/l

1.29

138

393

Special screening examination for infectious and parasitic diseases

195

616

2.32

24.86

1.1

282.06

280.64

mg/l

0.09

174

575

Exposure to unspecified factor

697

3068

1.55

24.82

1.1

706.51

288.50

mg/l

0.51

643

2802

Erysipelas, including avohilmo

478

2100

1.69

24.71

1.1

297.28

424.48

mg/l

0.44

436

1908

Acute pancreatitis

144

562

2.59

24.69

1.1

281.46

285.08

mg/l

0.22

133

508

Asthma (mode)

508

1578

1.70

24.66

1.1

293.56

471.05

mg/l

0.47

464

1443

Cerebrovascular diseases (FINNGEN)

212

668

2.24

24.55

1.1

1.0

291.90

288.23

mg/l

0.29

193

615

Asthma, unspecified (mode)

366

1455

1.82

24.31

1.1

293.44

487.74

mg/l

0.48

333

1333

Other diseases of intestine

123

447

2.78

24.30

1.1

1.0

294.85

289.91

mg/l

0.32

115

405

Complications of surgical and medical care, not elsewhere classified

663

2844

1.56

24.24

1.1

296.02

391.30

mg/l

0.46

602

2605

Dialysis, with operation codes

112

388

2.93

24.23

1.1

293.06

280.14

mg/l

0.85

106

349

Gastroduodenal ulcer

155

631

2.47

24.11

1.1

293.56

286.67

mg/l

0.51

139

573

Factors influencing health status and contact with health services

189

392

2.43

24.04

1.1

1.0

282.19

282.63

mg/l

0.02

172

359

Phobic anxiety disorders

132

500

2.66

23.96

1.1

288.98

285.93

mg/l

0.17

122

465

Other noninfective gastroenteritis and colitis

190

855

2.24

23.68

1.1

287.56

288.98

mg/l

0.09

178

778

Abnormal findings on diagnostic imaging of other body structures

122

449

2.75

23.57

1.1

1.0

298.58

290.44

mg/l

0.59

115

406

Thiazolidinediones

270

3.30

23.42

1.1

1.0

289.20

286.53

mg/l

0.12

249

Use of levodopa decarboxylase inhibitor

103

349

2.98

23.17

1.0

273.10

287.67

mg/l

1.37

312

Atrial fibrillation and flutter

208

609

2.22

23.14

1.0

1.1

1666.63

285.36

mg/l

0.51

195

559

Soft tissue disorders

674

2226

1.56

23.07

1.1

285.35

288.63

mg/l

0.45

613

2053

Certain infectious and parasitic diseases, including avohilmo

458

1341

1.72

22.98

1.1

290.49

501.92

mg/l

0.48

418

1231

L04AD Calcineurin inhibitors

114

411

2.82

22.97

1.1

291.71

286.05

mg/l

0.23

109

376

Other systemic involvement of connective tissue (FG)

189

847

2.21

22.71

1.1

295.98

295.92

mg/l

0.00

177

770

Dysphagia

157

664

2.38

22.67

1.1

294.08

288.28

mg/l

0.39

142

602

Gastric ulcer

112

402

2.81

22.66

1.1

292.95

289.67

mg/l

0.17

367

Benign neoplasm of other and ill-defined parts of digestive system

141

570

2.50

22.54

1.1

1.0

295.18

291.52

mg/l

0.20

127

519

Asthma (only as main-diagnosis)

468

1560

1.68

22.43

1.1

293.17

473.19

mg/l

0.48

424

1428

Combinations of oral blood glucose lowering drugs

181

818

2.23

22.39

1.1

1.0

287.53

285.85

mg/l

0.11

164

748

Pain, not elsewhere classified

201

947

2.14

22.39

1.1

294.77

288.86

mg/l

0.46

189

858

Other systemic involvement of connective tissue

194

902

2.17

22.37

1.1

295.70

293.76

mg/l

0.14

182

813

Parkinson's disease, including avohilmo

109

389

2.83

22.32

1.0

271.01

288.06

mg/l

1.77

100

352

Other disorders of urethra and urinary system

453

1892

1.67

22.17

1.0

1.1

292.78

450.65

mg/l

0.51

415

1718

Purpura and other haemorrhagic conditions

119

448

2.69

22.03

1.1

1.0

293.91

288.32

mg/l

0.27

110

405

Erysipelas

353

1730

1.77

21.89

1.1

298.18

282.53

mg/l

2.75

316

1567

Missing teeth due to accident, extraction or parodontitis

403

2136

1.69

21.56

1.1

1.0

290.25

426.90

mg/l

0.50

354

1943

Polyarthropathies

459

1788

1.65

21.30

1.1

291.01

452.19

mg/l

0.49

435

1638

Complications of medical and surgical care

485

2721

1.61

21.26

1.1

296.95

397.83

mg/l

0.46

431

2494

Other heart diseases, wide

631

2493

1.54

21.25

1.0

1.1

293.47

285.88

mg/l

1.51

572

2295

Abnormalities of heart beat

239

1184

1.97

21.23

1.1

285.03

290.23

mg/l

0.52

213

1073

Concussion

325

1403

1.80

21.22

1.1

1159.75

291.89

mg/l

0.49

303

1296

Dermatitis and eczema

741

2962

1.48

21.17

1.1

294.46

386.12

mg/l

0.45

687

2699

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

122

3.94

21.17

1.0

1.1

290.47

290.31

mg/l

0.01

111

Other functional intestinal disorders

293

1451

1.84

21.11

1.1

293.12

491.02

mg/l

0.49

263

1333

Fall on same level

766

2769

1.48

20.98

1.1

289.34

288.85

mg/l

0.06

687

2555

Diseases of the skin and subcutaneous tissue

634

2070

1.54

20.83

1.0

1.1

290.66

426.31

mg/l

0.48

580

1894

Sleep disorders (combined)

702

2449

1.50

20.63

1.1

290.72

406.33

mg/l

0.48

637

2248

Other CVD (FINNGEN)

183

3.37

20.52

1.1

294.76

287.54

mg/l

0.28

172

Biological medication for rheuma

167

759

2.22

20.49

1.1

279.66

287.00

mg/l

0.59

158

702

Myalgia

183

865

2.13

20.29

1.1

283.10

291.43

mg/l

0.81

163

790

Other ulcerative colitis

191

3.58

20.12

1.1

289.05

286.47

mg/l

0.10

172

Complications of procedures, not elsewhere classified

529

2743

1.56

20.03

1.1

296.62

395.93

mg/l

0.46

483

2509

Nephropathy related operations

106

396

2.71

19.99

1.1

288.40

282.47

mg/l

0.30

101

360

Other specific joint derangements/joint disorders

515

2034

1.58

19.93

1.1

287.70

432.47

mg/l

0.51

464

1866

Neoplasms

524

1735

1.59

19.88

1.1

285.33

448.22

mg/l

0.49

485

1612

Chronic pancreatitis

358

2.80

19.86

1.1

281.32

284.47

mg/l

0.14

326

Hypothyroidism, other/unspecified

564

2407

1.54

19.84

1.1

297.53

411.51

mg/l

0.46

504

2208

Oxycodone

246

1104

1.91

19.77

1.1

1.0

307.78

287.37

mg/l

3.38

217

1004

Diseases of the musculoskeletal system and connective tissue

375

1086

1.74

19.75

1.1

287.33

288.58

mg/l

0.10

347

1010

Other pulmonary diagnosis

504

1579

1.60

19.67

1.1

286.95

470.78

mg/l

0.50

463

1447

Any death

392

1638

1.68

19.66

1.1

294.58

286.15

mg/l

1.09

345

1495

Hyperkalaemia

130

4.14

19.65

1.1

1.0

315.72

283.88

mg/l

2.28

116

Episodal and paroxysmal disorders

698

2388

1.49

19.48

1.1

284.60

291.32

mg/l

1.56

631

2196

Gout, FINNGEN

172

801

2.15

19.45

1.0

1.1

296.75

282.17

mg/l

1.55

157

724

Other disorders of skin and subcutaneous tissue, not elsewhere classified

116

460

2.55

19.39

1.1

1.0

303.15

286.71

mg/l

1.23

103

420

Vocal cord dysfunction

257

3.00

19.34

1.1

280.97

290.32

mg/l

0.70

239

Other symptoms and signs involving cognitive functions and awareness

290

1435

1.80

19.31

1.1

1.0

287.86

290.82

mg/l

0.26

259

1302

Parkinson's disease

102

381

2.70

19.22

1.0

272.99

288.27

mg/l

1.47

344

Dorsopathies

662

2244

1.50

19.17

1.1

287.82

418.26

mg/l

0.51

605

2068

Excluding asthma or asthma-COPD overlap

500

1579

1.59

18.91

1.1

287.10

470.78

mg/l

0.50

461

1447

COPD differential diagnosis

499

1578

1.59

18.78

1.1

287.84

471.05

mg/l

0.49

460

1443

ILD differential diagnosis

498

1578

1.59

18.59

1.1

287.83

471.05

mg/l

0.49

459

1443

Benign neoplasms

637

2326

1.49

18.55

1.1

287.67

410.25

mg/l

0.49

580

2152

Parkinson's disease, strict definition

356

2.72

18.37

1.0

274.41

287.98

mg/l

1.22

319

Non-ischemic cardiomyopathy

185

714

2.07

18.22

1.0

1.1

307.35

288.76

mg/l

2.73

169

635

Thrombocytopenia, unspecified

224

3.22

18.19

1.1

1.0

286.25

285.97

mg/l

0.01

203

Disorders of the thyroid gland

592

2568

1.50

18.15

1.1

297.16

403.19

mg/l

0.46

532

2353

Hyperkinetic disorders, excluding more controls

103

369

2.63

18.12

1.1

277.39

282.12

mg/l

0.23

350

Social phobias

304

2.86

18.04

1.0

1.1

296.09

284.12

mg/l

0.69

279

Hypothyreosis and Thyroxine purchase for inclusion criteria

573

2498

1.51

18.01

1.1

297.18

407.53

mg/l

0.47

512

2292

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

570

2208

1.51

17.90

1.1

297.09

419.39

mg/l

0.45

527

2018

570

2208

1.51

17.90

1.1

297.09

419.39

mg/l

0.45

527

2018

Use of hypnotics and sedatives

680

2670

1.46

17.80

1.1

292.75

397.53

mg/l

0.47

618

2443

Disorder of lipoprotein metabolism, unspecified

312

2.81

17.76

1.0

1.1

298.08

284.18

mg/l

0.93

281

Other diseases of upper respiratory tract

682

2439

1.46

17.60

1.1

287.06

408.71

mg/l

0.52

609

2248

Convulsions, not elsewhere classified

163

770

2.10

17.55

1.1

282.85

283.61

mg/l

0.05

147

705

Other dorsopathies, not elsewhere classified

634

2231

1.48

17.47

1.1

288.71

419.25

mg/l

0.50

580

2055

Gout, strict definition

116

485

2.41

17.34

1.0

1.1

296.30

278.99

mg/l

1.48

105

443

Gout

172

717

2.07

17.32

1.0

1.1

296.75

284.04

mg/l

1.23

157

651

Other blood glucose lowering drugs, excl. Insulins

374

2.62

17.21

1.1

281.47

288.68

mg/l

0.45

337

Other disorders of skin and subcutaneous tissue

458

2501

1.55

17.19

1.1

298.93

406.49

mg/l

0.45

410

2290

Nerve, nerve root and plexus disorders

669

2776

1.45

17.19

1.1

289.45

289.70

mg/l

0.03

609

2534

Acute pancreatitis (for exclusion)

144

663

2.19

17.18

1.1

1.0

281.46

284.41

mg/l

0.18

133

603

Other bacterial intestinal infections

126

549

2.31

17.16

1.1

1.0

292.61

285.44

mg/l

0.54

115

495

Accidents

497

1606

1.55

17.11

1.1

292.07

288.34

mg/l

0.43

450

1478

Other external causes of accidental injury

497

1606

1.55

17.11

1.1

291.52

288.34

mg/l

0.35

450

1478

Gout, idiopatic and unspecified

150

703

2.15

17.09

1.0

1.1

296.12

281.09

mg/l

1.48

136

641

Gout, unspecified

128

563

2.29

17.05

1.0

1.1

301.90

281.46

mg/l

2.02

114

511

Other bacterial intestinal infections, including avohilmo

160

772

2.09

16.91

1.1

1.0

290.17

287.75

mg/l

0.17

148

695

Noninfectious colitis NAS

110

456

2.44

16.80

1.1

291.56

291.65

mg/l

0.00

101

416

Sciatica+with lumbago

337

1810

1.65

16.72

1.0

1.1

283.33

451.49

mg/l

0.53

303

1665

Heart failure and coronary heart disease

230

866

1.87

16.62

1.0

1.1

313.08

286.41

mg/l

5.60

213

768

Other and unspecified dermatitis

342

2096

1.64

16.62

1.1

294.35

429.07

mg/l

0.47

320

1903

Acute peritonitis

191

3.30

16.56

1.1

1.0

285.16

284.10

mg/l

0.04

175

Implicit fungal Sepsis, including avohilmo

192

3.27

16.40

1.1

1.0

294.84

287.99

mg/l

0.28

175

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

629

2746

1.45

16.35

1.1

293.45

395.04

mg/l

0.47

584

2508

Influenza and pneumonia

684

2968

1.43

16.09

1.1

294.29

385.33

mg/l

0.45

630

2714

Acute upper respiratory infections of multiple and unspecified sites

505

2459

1.50

16.05

1.1

296.77

405.28

mg/l

0.45

456

2255

Acute upper respiratory infections

654

2733

1.44

16.04

1.1

297.74

395.63

mg/l

0.45

593

2499

Fibromyalgia

302

2.75

15.99

1.1

1.0

299.03

296.54

mg/l

0.09

274

Dermatitis

399

2502

1.56

15.99

1.1

297.91

406.54

mg/l

0.45

372

2277

Abnormal findings on diagnostic imaging of lung

271

1492

1.73

15.98

1.1

1.0

296.81

287.10

mg/l

1.35

253

1352

Papulosquamous disorders

264

1531

1.73

15.87

1.0

1.1

296.95

287.43

mg/l

1.04

240

1391

Finngen Rheumatological endpoints

620

2433

1.45

15.77

1.1

285.11

408.21

mg/l

0.52

561

2236

Symptoms and signs involving the urinary system

470

2343

1.52

15.75

1.1

284.84

289.21

mg/l

0.62

415

2145

Falls/tendency to fall

684

2403

1.43

15.70

1.1

294.52

288.24

mg/l

1.10

619

2219

Genitourinary diseases

382

1186

1.62

15.69

1.1

279.20

524.26

mg/l

0.50

358

1090

Obesity related asthma

241

1370

1.77

15.56

1.0

1.1

289.93

288.65

mg/l

0.12

214

1245

Parasetamol

489

1627

1.52

15.48

1.1

289.58

283.32

mg/l

0.88

455

1493

Poisoning by drugs, medicaments and biological substances

186

978

1.92

15.47

1.1

293.10

285.47

mg/l

0.58

161

901

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

375

2352

1.57

15.22

1.1

300.55

291.86

mg/l

1.16

335

2147

Diseases of peritoneum

311

2.67

15.13

1.1

1.0

287.66

289.55

mg/l

0.08

284

Bacterial intestinal infections, IBD co-morbidities

126

580

2.19

15.10

1.1

1.0

292.30

287.81

mg/l

0.29

115

524

Crohn's disease of small intestine

247

2.88

14.85

1.1

279.51

286.16

mg/l

0.32

225

Infections of the skin and subcutaneous tissue

393

2517

1.54

14.79

1.1

297.44

284.23

mg/l

2.22

366

2305

Tumor necrosis factor alpha inhibitors

140

678

2.08

14.76

1.1

272.76

286.56

mg/l

1.54

131

626

Sicca syndrome [Sjögren]

248

2.86

14.73

1.1

1.0

301.39

296.69

mg/l

0.22

219

Statin medication

454

1683

1.52

14.73

1.1

288.69

460.37

mg/l

0.50

416

1545

Bronchitis

682

2921

1.40

14.71

1.1

296.07

387.50

mg/l

0.45

614

2684

Cough

258

1413

1.71

14.71

1.1

290.41

496.88

mg/l

0.50

235

1294

COPD/asthma/ILD related infections

630

2208

1.43

14.70

1.1

295.87

419.39

mg/l

0.46

578

2018

COPD/asthma related infections

630

2208

1.43

14.70

1.1

295.87

419.39

mg/l

0.46

578

2018

Other diseases of anus and rectum

175

914

1.92

14.67

1.1

298.12

291.85

mg/l

0.48

164

832

Poisoning by medicine

171

892

1.93

14.61

1.1

295.95

285.75

mg/l

0.82

148

824

Diverticular disease of intestine

408

1647

1.55

14.48

1.1

292.43

464.86

mg/l

0.49

360

1516

Psoriasis

199

1095

1.83

14.39

1.1

297.19

287.69

mg/l

0.79

182

1000

Heart failure and bmi 25plus

210

767

1.83

14.28

1.0

1.1

308.44

278.26

mg/l

7.01

196

675

Generalized anxiety disorder

127

602

2.12

14.11

1.1

294.83

289.08

mg/l

0.33

120

561

Hypothyroidism, strict autoimmune, 3 medication purchases required

499

2288

1.47

14.09

1.1

297.16

419.76

mg/l

0.48

442

2096

Certain disorders involving the immune mechanism

138

677

2.05

14.07

1.1

1.0

299.76

284.41

mg/l

1.41

131

617

Cholecystitis

341

2.51

13.98

1.1

1.0

298.14

289.63

mg/l

0.27

307

Spondylopathies

464

1840

1.49

13.96

1.1

284.37

448.91

mg/l

0.53

418

1690

Dizziness and giddiness

452

2369

1.49

13.94

1.1

287.16

414.52

mg/l

0.52

410

2166

Hard cardiovascular diseases

520

2110

1.46

13.90

1.1

290.65

426.73

mg/l

0.49

473

1927

Unspecified urinary incontinence

245

2.81

13.88

1.1

1.0

288.49

296.58

mg/l

0.44

219

All pneumoniae

645

3002

1.40

13.88

1.1

295.37

384.29

mg/l

0.44

598

2743

Other intervertebral disc disorders

494

2007

1.47

13.76

1.1

285.39

435.82

mg/l

0.53

449

1845

Pneumonias (Asthma/COPD co-morbidities)

640

2997

1.40

13.73

1.1

296.12

384.40

mg/l

0.44

593

2740

Type 1 diabetes

162

849

1.92

13.60

1.1

306.69

282.65

mg/l

2.85

145

782

Exposure to other specified factors

522

3130

1.44

13.59

1.1

286.59

381.90

mg/l

0.52

473

2874

Asthma, hospital admission 2, infections

370

2362

1.53

13.58

1.1

298.35

288.31

mg/l

1.54

335

2163

Asthma-related infections

370

2362

1.53

13.58

1.1

298.35

288.31

mg/l

1.54

335

2163

Benign neoplasm: Colon, unspecified

150

768

1.97

13.56

1.1

1.0

293.47

284.94

mg/l

0.71

124

696

Personality disorders

201

1132

1.79

13.49

1.1

292.17

287.44

mg/l

0.43

178

1048

Cerebral cysts

195

3.02

13.46

1.1

276.83

290.12

mg/l

0.71

178

Other diseases of urinary system

592

2349

1.42

13.42

1.1

290.40

414.13

mg/l

0.50

547

2147

688

2521

1.39

13.42

1.1

297.57

403.85

mg/l

0.45

626

2309

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

346

2239

1.55

13.32

1.1

297.51

291.23

mg/l

0.85

310

2038

Other and unspecified disorders of skin and subcutaneous tissue

191

3.03

13.30

1.1

1.0

303.91

291.82

mg/l

0.39

173

Other/unspecified dorsalgia

231

1341

1.71

13.28

1.1

293.59

291.43

mg/l

0.13

214

1224

Somatoform disorder

120

573

2.11

13.18

1.1

284.35

289.36

mg/l

0.30

105

524

Other CVD

111

514

2.17

13.16

1.1

1.0

294.89

287.77

mg/l

0.38

469

Elevated blood glucose level

242

2.76

13.06

1.1

281.66

284.65

mg/l

0.10

219

Psoriasis vulgaris

137

690

2.00

13.03

1.1

298.64

284.89

mg/l

0.94

124

633

Pneumonia, organism unspecified

576

2813

1.41

13.00

1.1

297.29

390.87

mg/l

0.44

533

2571

Chronic sinusitis

270

1667

1.62

12.82

1.1

294.54

290.53

mg/l

0.37

246

1537

Other diseases of blood and blood-forming organs, wide

147

764

1.94

12.76

1.0

312.25

287.30

mg/l

2.13

132

692

Sulfonylureas

144

582

1.97

12.72

1.0

298.74

292.43

mg/l

0.46

129

525

Disorders of adult personality and behaviour

207

1197

1.74

12.71

1.1

296.42

285.87

mg/l

1.08

182

1110

Paralytic ileus and intestinal obstruction

142

732

1.95

12.57

1.1

303.86

290.88

mg/l

1.05

126

662

Symptoms and signs concerning food and fluid intake

293

2.54

12.52

1.1

1.0

280.24

290.67

mg/l

0.60

264

Injuries to the knee and lower leg

730

2930

1.35

12.26

1.1

288.76

388.77

mg/l

0.51

658

2688

Care involving dialysis

245

2.69

12.24

1.1

293.75

278.45

mg/l

0.80

226

Injuries to the head

688

3013

1.36

12.21

1.1

697.38

291.46

mg/l

0.48

637

2748

Ulcer of lower limb, not elsewhere classified

414

2.26

12.20

1.1

1.0

300.92

280.80

mg/l

1.64

378

Chronic periodontitis, complicated

345

2223

1.52

12.18

1.1

294.71

418.49

mg/l

0.46

307

2034

Polycystic ovarian syndrome, consortium definition

417

1615

1.49

12.16

1.1

301.15

484.68

mg/l

0.51

378

1466

Symptoms and signs involving speech and voice

204

1190

1.72

12.15

1.0

1.1

288.66

293.75

mg/l

0.46

184

1076

Substance use, excluding alcohol

147

779

1.90

12.07

1.0

1.1

301.56

282.32

mg/l

2.86

133

721

Familial hypercholesterolemia

323

2.43

12.06

1.0

1.1

288.10

284.60

mg/l

0.16

286

Covid-19 confirmed case

215

1273

1.69

12.05

1.0

1.1

299.13

288.09

mg/l

1.32

194

1157

Vascular disorders of the intestines

149

3.19

12.04

1.0

292.17

296.25

mg/l

0.13

131

KRA_PSY_EATING, excluding more controls

200

2.85

12.02

1.1

290.25

306.40

mg/l

0.74

188

Hernia of abdominal wall

272

1717

1.59

11.90

1.1

290.16

285.12

mg/l

0.54

252

1567

Osteopathies and chondropathies

339

2048

1.52

11.88

1.1

300.56

289.88

mg/l

1.47

305

1865

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

205

1208

1.71

11.80

1.1

294.54

288.20

mg/l

0.52

184

1113

Percutaneous Coronary Intervention

473

2008

1.44

11.77

1.0

1.1

290.92

434.49

mg/l

0.49

433

1824

External causes of morbidity and mortality

386

1287

1.51

11.77

1.1

293.01

287.59

mg/l

0.64

354

1190

Coronary revascularization (ANGIO or CABG)

474

2011

1.44

11.75

1.0

1.1

291.00

434.20

mg/l

0.49

434

1827

Early onset COPD, excluding more controls

120

598

2.02

11.75

1.0

1.1

302.64

283.03

mg/l

2.13

107

539

Spondyloarthritis

117

579

2.03

11.72

1.1

291.26

287.92

mg/l

0.18

107

532

Nonorganic sleeping disorders, excluding more controls

133

689

1.94

11.69

1.1

291.32

287.64

mg/l

0.18

121

640

Disorders of other endocrine glands

270

1682

1.59

11.65

1.1

297.43

289.67

mg/l

0.73

247

1538

Acute tubulo-interstitial nephritis

345

1936

1.51

11.63

1.1

298.21

291.90

mg/l

0.82

316

1747

Malignant neoplasm of digestive organs, including Hilmo

249

1125

1.63

11.58

1.1

1.0

294.78

285.66

mg/l

1.02

231

1024

Transport accidents

283

1504

1.57

11.46

1.1

283.49

287.69

mg/l

0.45

260

1388

Irregular menses

301

1460

1.55

11.42

1.1

298.17

501.87

mg/l

0.51

279

1331

Menorrhagia

195

618

1.77

11.41

1.1

303.40

782.90

mg/l

0.50

173

557

Major coronary heart disease event

497

2106

1.42

11.39

1.0

1.1

290.10

427.35

mg/l

0.49

453

1911

Hyperlipidaemia, other/unspecified

201

1065

1.70

11.35

1.1

291.47

288.59

mg/l

0.22

177

956

Emergency coronary revascularization (for ACS)

495

2118

1.41

11.33

1.0

1.1

290.40

427.18

mg/l

0.49

453

1918

Cystitis

480

2011

1.42

11.33

1.1

293.23

439.54

mg/l

0.50

449

1830

Chronic periodontitis, including avohilmo

603

2823

1.37

11.32

1.1

290.20

392.31

mg/l

0.50

533

2596

Hypertensive Heart Disease

119

447

2.03

11.29

1.0

1.1

301.51

287.51

mg/l

1.25

106

410

Schizophrenia or delusion, excluding more controls

182

1037

1.74

11.28

1.1

287.40

283.54

mg/l

0.30

169

959

285

1827

1.55

11.27

1.1

300.09

287.19

mg/l

1.80

257

1675

Diaphragmatic hernia

204

1216

1.69

11.26

1.1

302.03

289.78

mg/l

1.67

183

1106

Periodontitis

604

2828

1.36

11.25

1.1

290.27

391.94

mg/l

0.49

535

2600

Hypertensive heart and/or renal disease

129

480

1.97

11.23

1.0

1.1

301.65

287.38

mg/l

1.45

117

440

Coeliac disease

398

2.23

11.17

1.2

1.0

281.00

292.40

mg/l

0.69

367

Hypotension

432

2.17

11.02

1.1

1.0

297.14

286.24

mg/l

0.58

390

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

612

3014

1.35

11.01

1.1

296.47

383.91

mg/l

0.44

568

2755

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

318

2037

1.51

11.01

1.1

278.61

429.61

mg/l

0.55

280

1887

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

164

802

1.79

11.01

1.1

282.04

281.87

mg/l

0.01

152

753

Other joint disorders

550

2071

1.39

11.00

1.1

284.29

429.47

mg/l

0.52

499

1901

Syncope and collapse

240

1244

1.62

10.97

1.1

290.34

285.86

mg/l

0.34

222

1117

Chronic lower respiratory diseases

734

2922

1.33

10.94

1.1

291.73

387.18

mg/l

0.47

668

2677

Disorders of lens

396

1684

1.46

10.92

1.1

286.65

462.19

mg/l

0.51

352

1543

Ischemic heart diseases

496

2108

1.40

10.89

1.0

1.1

288.11

427.16

mg/l

0.50

451

1919

Panic disorder

110

549

2.02

10.82

1.2

1.1

288.55

289.64

mg/l

0.04

509

Other diseases of lip and oral mucosa

268

1727

1.56

10.79

1.1

295.13

290.93

mg/l

0.36

244

1565

Abnormal weight loss

287

2.43

10.65

1.1

1.0

279.35

292.28

mg/l

0.72

258

Migraine

324

1683

1.50

10.64

1.1

285.85

295.73

mg/l

1.65

302

1554

Intestinal stricture

171

988

1.74

10.61

1.1

1.0

297.32

287.52

mg/l

0.83

153

894

Special screening examination for other diseases and disorders

318

2.34

10.57

1.0

1.1

274.78

283.61

mg/l

0.51

286

Rheumatism, unspecified

440

2.13

10.57

1.1

304.48

296.61

mg/l

0.55

398

Asthma (diagnoses ohter than nonallergic)

527

3114

1.37

10.52

1.1

293.51

382.23

mg/l

0.47

479

2858

Symptoms and signs involving the skin and subcutaneous tissue

432

2899

1.41

10.49

1.1

290.08

391.74

mg/l

0.50

401

2639

Cutaneous abscess, furuncle and carbuncle

176

1029

1.72

10.49

1.1

312.42

283.88

mg/l

3.45

156

941

Pain and other conditions associated with female genital organs and menstrual cycle

132

586

1.89

10.49

1.1

312.50

802.70

mg/l

0.49

121

534

Candidiasis, including avohilmo

192

1150

1.68

10.46

1.1

296.24

291.85

mg/l

0.34

176

1045

Speech disturbances, not elsewhere classified

254

2.50

10.40

1.0

277.91

291.75

mg/l

0.72

227

Chronic diseases of tonsils and adenoids

490

2225

1.39

10.38

1.1

287.87

418.63

mg/l

0.51

446

2058

Cardiomyopathy

478

2.06

10.26

1.0

1.1

308.26

279.17

mg/l

3.11

439

Enlarged lymph nodes

472

2.07

10.24

1.1

308.40

285.26

mg/l

1.52

431

Other diseases of hard tissues of teeth

305

1034

1.53

10.19

1.0

285.29

289.22

mg/l

0.36

276

960

Urinary track infection

344

1156

1.49

10.17

1.1

301.06

558.75

mg/l

0.51

320

1047

Asthma, hospital admissions , main diagnosis only

491

3113

1.37

10.15

1.1

294.62

381.94

mg/l

0.46

447

2854

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

127

684

1.87

10.02

1.1

295.20

287.33

mg/l

0.44

108

637

Use of pramipexole

129

698

1.86

10.02

1.0

1.1

296.65

290.63

mg/l

0.43

119

631

Acute alcohol intoxication

156

895

1.75

9.97

1.1

289.83

281.31

mg/l

0.75

145

826

Acute gastritis

195

2.69

9.95

1.1

293.49

291.70

mg/l

0.07

179

Excessive, frequent and irregular menstruation

209

674

1.66

9.82

1.1

294.06

740.36

mg/l

0.52

185

611

Diseases of oral cavity, salivary glands and jaws

304

1034

1.52

9.77

1.0

288.32

289.22

mg/l

0.07

274

960

Diseases of the respiratory system

367

1261

1.46

9.76

1.1

294.55

517.49

mg/l

0.48

335

1157

Chronic apical periodontitis

659

2804

1.32

9.75

1.1

290.86

391.90

mg/l

0.49

581

2591

Asthma, including avohilmo

710

2996

1.31

9.75

1.1

292.69

385.12

mg/l

0.47

648

2744

Explicit bacterial Sepsis, including avohilmo

305

2.31

9.75

1.1

305.63

283.71

mg/l

1.31

277

Injuries to the ankle and foot

462

2869

1.38

9.71

1.1

289.32

389.11

mg/l

0.49

434

2629

Provisional assignment of new diseases of uncertain etiology

310

2096

1.47

9.56

1.0

1.1

299.21

289.76

mg/l

1.41

275

1918

Open wound of head

325

2098

1.46

9.54

1.1

278.22

285.54

mg/l

1.10

301

1912

Calcific aortic valvular stenosis, diagnosis (helper)

127

667

1.84

9.54

1.0

310.18

287.38

mg/l

2.83

114

602

Operations 2 for CAVS

127

667

1.84

9.54

1.0

310.18

287.38

mg/l

2.83

114

602

Codes for special purposes

310

2097

1.47

9.53

1.0

1.1

299.21

289.79

mg/l

1.40

275

1919

Glomerular diseases

115

611

1.89

9.49

1.1

1.0

305.84

285.25

mg/l

1.80

106

560

Other and unspecified effects of external causes

185

1128

1.65

9.46

1.1

283.76

287.96

mg/l

0.33

173

1034

Calcific aortic valvular stenosis, operated

127

669

1.83

9.45

1.0

310.18

287.34

mg/l

2.84

114

604

Calcific aortic valvular stenosis

127

669

1.83

9.45

1.0

310.18

287.34

mg/l

2.84

114

604

Explicit bacterial Sepsis

297

2.31

9.43

1.1

304.62

283.00

mg/l

1.23

270

Enterocolitis due to Clostridium difficile

291

2.32

9.42

1.1

1.0

302.27

294.26

mg/l

0.39

260

Weight loss

310

2.28

9.42

1.1

1.0

277.64

294.47

mg/l

1.06

280

Pleural effusion

407

2.10

9.41

1.0

331.42

284.61

mg/l

3.25

365

Senile cataract

345

1444

1.46

9.38

1.1

286.33

492.53

mg/l

0.51

306

1319

Calcific aortic valvular stenosis, including rheumatic fever

127

670

1.83

9.38

1.0

310.18

287.46

mg/l

2.82

114

605

Acute alcohol intoxication, ICD10

138

780

1.78

9.33

1.1

289.73

279.54

mg/l

0.88

128

719

Other or unspecified ileus, impaction or obstruction

491

1.98

9.21

1.1

1.0

305.45

290.80

mg/l

0.89

443

Cardiomyopathies, Primary/intrinsic

340

2.19

9.12

1.0

1.1

311.10

274.38

mg/l

3.33

314

Ulcerative enterocolitis

101

3.33

9.07

1.2

1.1

291.79

283.99

mg/l

0.19

Other Crohn's disease

247

2.42

9.05

1.1

283.81

282.23

mg/l

0.06

228

Maternal care for other conditions predominantly related to pregnancy

136

753

1.77

9.02

1.1

301.54

301.58

mg/l

0.00

123

689

Asthma-related pneumonia or sepsis

196

1224

1.60

8.98

1.1

301.83

290.11

mg/l

0.98

176

1104

Asthma, hospital admissions 3, pneumonia

196

1224

1.60

8.98

1.1

301.83

290.11

mg/l

0.98

176

1104

Non-selective monoamine reuptake inhibitors

196

1177

1.60

8.97

1.1

294.99

537.95

mg/l

0.49

179

1079

Diagnoses used for exclusion with ILD

142

820

1.74

8.92

1.1

299.46

285.01

mg/l

1.40

134

746

Benign neoplasm: Stomach

286

2.29

8.91

1.0

297.04

292.95

mg/l

0.19

256

Other headache syndromes

248

1637

1.51

8.89

1.1

1464.74

294.96

mg/l

0.49

226

1492

Diseases of the eye and adnexa

503

1859

1.36

8.89

1.1

285.17

440.16

mg/l

0.50

465

1717

Shoulder lesions

424

1835

1.39

8.83

1.0

1.1

287.68

289.90

mg/l

0.24

383

1685

Asthma-related pneumonia

195

1222

1.60

8.82

1.1

302.24

290.09

mg/l

1.03

175

1102

Suicide or other Intentional self-harm

167

1012

1.66

8.80

1.1

297.27

285.84

mg/l

0.99

147

931

Specific personality disorders

163

983

1.67

8.75

1.1

293.72

287.28

mg/l

0.53

142

911

Injuries to the thorax

257

1721

1.50

8.72

1.1

282.42

285.54

mg/l

0.26

234

1573

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

227

2.45

8.71

1.1

311.56

293.70

mg/l

0.60

213

Streptococcal septicaemia, including avohilmo

258

2.34

8.67

1.1

304.49

282.88

mg/l

1.14

234

Urticaria and erythema

228

1492

1.53

8.67

1.2

1.1

283.42

291.27

mg/l

0.88

209

1362

Inflammatory diseases of female pelvic organs

353

1704

1.42

8.65

1.0

1.1

308.73

474.21

mg/l

0.47

324

1542

Care involving use of rehabilitation procedures

371

2392

1.40

8.62

1.1

296.23

410.37

mg/l

0.46

333

2187

Injury, poisoning and certain other consequences of external causes

310

1058

1.47

8.62

1.1

295.85

289.31

mg/l

0.68

282

968

Arthropathies

547

2076

1.33

8.61

1.1

282.09

429.09

mg/l

0.53

508

1906

Pacemaker

164

922

1.66

8.58

1.0

1.1

306.95

287.09

mg/l

2.88

151

834

Infections with a predominantly sexual mode of transmission

201

1280

1.57

8.56

1.1

294.89

288.90

mg/l

0.39

175

1177

Infliximab

3.49

8.55

1.1

262.55

281.91

mg/l

0.71

Glomerular disorders in diseases classified elsewhere

383

2.08

8.52

1.1

312.31

284.68

mg/l

2.29

347

Disturbance of activity and attention

101

521

1.90

8.49

1.1

277.68

284.13

mg/l

0.33

486

Other diseases of pleura

219

1240

1.54

8.33

1.1

306.90

285.64

mg/l

2.65

194

1122

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

276

2.27

8.30

1.1

310.16

293.95

mg/l

0.57

253

Diseases of the myoneural junction and muscle

394

2.05

8.28

1.0

1.1

282.46

287.02

mg/l

0.19

356

Streptococcal septicaemia

251

2.33

8.28

1.1

1.0

303.24

282.76

mg/l

1.01

227

Type 1 diabetes, wide definition, subgroup 1

124

705

1.77

8.24

1.2

1.1

312.56

281.98

mg/l

3.47

111

651

Acetic acid derivatives and related substances

145

430

1.75

8.22

1.0

1.1

292.09

292.58

mg/l

0.02

128

393

Other medical care

262

1492

1.48

8.17

1.1

297.69

288.83

mg/l

1.09

236

1341

Unspecified mental disorder

251

1698

1.48

8.16

1.1

287.24

285.84

mg/l

0.11

229

1563

Neuromuscular dysfunction of bladder

291

2.22

8.15

1.1

289.57

291.62

mg/l

0.08

268

Caries of enamel

588

2964

1.30

8.11

1.1

288.12

386.77

mg/l

0.51

528

2722

Presence of cardiac and vascular implants and grafts

213

1015

1.55

8.10

1.1

1.0

300.22

284.58

mg/l

2.09

195

911

Cardiomyopathy (excluding other)

357

2.09

8.10

1.0

1.1

311.10

273.31

mg/l

3.51

329

Fissure and fistula of anal and rectal regions

137

810

1.70

7.97

1.1

298.91

289.47

mg/l

0.49

121

736

Coronary atherosclerosis

340

1524

1.41

7.92

1.0

1.1

288.36

286.31

mg/l

0.20

311

1373

Intracranial injury

335

2237

1.40

7.90

1.1

1143.21

288.67

mg/l

0.49

309

2047

Acute sinusitis

326

2114

1.41

7.88

1.1

291.40

287.88

mg/l

0.39

304

1943

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

121

2.93

7.87

1.0

302.41

288.32

mg/l

0.45

106

Mental and behavioural disorders due to tobacco

322

2.13

7.85

1.0

1.1

289.27

292.35

mg/l

0.13

298

Disorders of skin appendages

306

2156

1.42

7.81

1.1

290.44

288.05

mg/l

0.18

277

1976

Diabetic maculopathy, excluding more controls

303

2.16

7.79

1.1

299.84

279.73

mg/l

1.26

273

Other metabolic disorders

424

1.97

7.78

1.1

304.90

292.45

mg/l

0.45

389

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

284

2.20

7.78

1.1

1.0

310.16

298.38

mg/l

0.37

259

Unspecified haematuria

218

1172

1.52

7.76

1.1

288.65

283.70

mg/l

0.40

199

1069

Fracture of shoulder and upper arm

209

1375

1.52

7.76

1.1

298.50

287.55

mg/l

1.25

186

1253

Superficial injury of lower leg

164

1023

1.61

7.75

1.0

1.1

292.76

289.78

mg/l

0.23

146

934

Paroxysmal tachycardia

116

543

1.78

7.75

1.0

1.1

292.35

288.68

mg/l

0.17

102

500

Intrahepatic Cholestasis of Pregnancy (ICP)

240

2.31

7.75

1.1

1.0

311.56

298.68

mg/l

0.39

224

Hyperkinetic disorders

104

558

1.83

7.75

1.1

277.84

284.39

mg/l

0.35

522

Diseases of arteries, arterioles and capillaries

336

1763

1.40

7.73

1.1

297.36

287.25

mg/l

1.50

292

1610

Smoking dependency

324

2.12

7.73

1.0

1.1

289.27

291.50

mg/l

0.09

301

Restless leg syndrome

488

1.90

7.73

1.1

1.0

284.58

293.05

mg/l

0.48

446

Fracture of rib(s), sternum and thoracic spine

166

1041

1.60

7.68

1.0

1.1

285.70

282.07

mg/l

0.22

151

950

Conjunctivitis (acute, non atopic), including avohilmo

600

2819

1.29

7.61

1.1

292.18

390.28

mg/l

0.47

534

2601

Diseases of salivary glands

196

1280

1.54

7.60

1.1

290.38

290.97

mg/l

0.04

180

1166

Enthesopathies of lower limb, excluding foot

140

844

1.67

7.59

1.1

286.77

289.75

mg/l

0.19

123

768

Fracture of lumbar spine and pelvis

112

633

1.77

7.59

1.1

1.0

290.33

290.06

mg/l

0.01

102

575

Ischaemic heart disease, wide definition

418

1905

1.35

7.58

1.0

1.1

288.09

443.46

mg/l

0.50

378

1719

Behavioural syndromes associated with physiological disturbances and physical factors

559

2925

1.29

7.57

1.1

294.90

387.50

mg/l

0.45

517

2672

Migraine with aura

154

953

1.62

7.52

1.1

291.86

296.45

mg/l

0.30

147

882

Diseases of the ear and mastoid process

685

2710

1.27

7.49

1.0

1.1

289.58

288.64

mg/l

0.11

627

2487

Exclusions for E4_PCOS_BROAD

116

667

1.75

7.48

1.1

308.55

284.41

mg/l

2.56

108

612

Other retinal disorders

336

1841

1.39

7.44

1.1

297.00

288.21

mg/l

1.15

307

1658

Spondylopathies (FG)

509

1.86

7.43

1.1

286.84

285.60

mg/l

0.06

469

Adalimumab

398

1.98

7.38

1.1

275.73

288.29

mg/l

0.92

364

STROKE

296

1404

1.42

7.36

1.1

285.39

497.86

mg/l

0.51

272

1273

Lumbar disc prolapse

358

1935

1.37

7.36

1.1

285.85

440.50

mg/l

0.52

329

1781

Type 1 diabetes, wide definition

126

745

1.70

7.34

1.2

1.1

311.66

282.04

mg/l

3.39

113

688

Gingivitis and periodontal diseases

548

2180

1.30

7.32

1.1

285.55

420.94

mg/l

0.51

487

2004

Visual disturbances and blindness

289

2054

1.41

7.24

1.1

292.49

290.30

mg/l

0.20

263

1867

Disorders of choroid and retina

439

2317

1.33

7.23

1.1

295.42

414.80

mg/l

0.46

401

2099

Urticaria

186

1216

1.54

7.20

1.2

1.1

283.20

291.42

mg/l

0.80

170

1109

Umbilical hernia

162

1028

1.58

7.17

1.1

1.0

293.55

279.22

mg/l

1.52

147

953

Injuries to the abdomen, lower back, lumbar spine and pelvis

220

1472

1.48

7.09

1.1

292.26

286.62

mg/l

0.48

197

1334

Pruritus

390

1.96

7.08

1.1

1.0

311.79

290.38

mg/l

1.37

359

Malignant neoplasm of digestive organs

204

1036

1.51

7.05

1.1

1.0

296.45

285.55

mg/l

1.09

187

942

Abnormal findings on diagnostic imaging of central nervous system

152

2.59

7.04

1.2

1.1

260.92

289.87

mg/l

1.45

135

Other disorders of lacrimal gland

212

1438

1.48

6.91

1.1

296.43

294.23

mg/l

0.15

193

1302

Exclusions for E4_PCOS_CONSORTIUM

411

1929

1.33

6.80

1.1

300.36

446.31

mg/l

0.48

374

1764

Kela-code for severe mental illness

216

1476

1.47

6.79

1.1

284.16

283.70

mg/l

0.03

197

1357

Cerebrovascular diseases

377

1949

1.34

6.73

1.1

289.24

289.87

mg/l

0.06

347

1761

Other complications of surgical and medical care, not elsewhere classified

331

2.01

6.60

1.1

1.0

304.71

292.37

mg/l

0.67

301

Disturbances of skin sensation

170

1113

1.53

6.59

1.1

284.53

291.13

mg/l

0.70

156

1017

Amputation

264

2.13

6.58

1.1

1.0

306.14

282.73

mg/l

1.00

237

Atopic dermatitis, strict definition with reimbursement

192

1238

1.49

6.57

1.0

1.1

298.36

288.01

mg/l

1.07

181

1138

Chronic rhinitis, nasopharyngitis and pharyngitis

191

1283

1.49

6.55

1.0

1.1

293.84

290.48

mg/l

0.21

170

1184

Delirium, not induced by alcohol and other psychoactive substances

325

2.01

6.50

1.1

1.0

290.51

288.22

mg/l

0.08

291

Diseases of pulp and periapical tissues, including avohilmo

578

2359

1.27

6.46

1.1

288.82

288.19

mg/l

0.06

516

2184

Atopic dermatitis

366

2192

1.33

6.33

1.1

295.10

286.78

mg/l

1.28

338

2011

Superficial injury of head

136

854

1.60

6.32

1.1

286.06

287.83

mg/l

0.11

126

776

Voice disturbances

149

958

1.56

6.29

1.0

1.1

292.41

294.16

mg/l

0.11

135

871

Disorders of synovium and tendon

295

1827

1.37

6.25

1.1

292.07

289.87

mg/l

0.19

266

1679

Disorders of parathyroid gland

105

613

1.70

6.22

1.0

301.18

294.40

mg/l

0.50

548

Persistent mood disorders

109

651

1.68

6.22

1.1

290.82

289.35

mg/l

0.07

100

591

Other and unspecified nonorganic psychotic disorders

134

844

1.60

6.20

1.1

289.61

283.66

mg/l

0.42

124

784

Dental operations

315

1183

1.37

6.14

1.0

287.25

292.38

mg/l

0.56

287

1086

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

196

1343

1.46

6.13

1.0

1.1

302.09

290.99

mg/l

1.29

187

1220

Vitamin B12 deficiency anaemia

259

2.10

6.10

1.1

1.0

292.82

290.75

mg/l

0.06

231

Rotator cuff syndrome

327

1670

1.35

6.09

1.0

1.1

1174.01

290.10

mg/l

0.50

300

1526

Coxibs

138

448

1.62

6.08

1.0

1.1

285.20

291.78

mg/l

0.33

127

411

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

384

2672

1.31

6.08

1.1

291.68

287.57

mg/l

0.41

351

2457

Fenamates

279

1.89

6.05

1.1

1.0

280.42

295.26

mg/l

1.28

252

Other abnormal uterine and vaginal bleeding

120

525

1.65

6.03

1.1

285.04

870.11

mg/l

0.53

107

473

Eating disorder

280

2.05

6.03

1.1

290.25

301.43

mg/l

0.46

264

Migraine without aura

127

796

1.60

6.00

1.1

286.79

296.19

mg/l

0.81

118

741

Disorders of lacrimal system

246

1734

1.40

5.99

1.1

296.04

465.50

mg/l

0.50

225

1567

DVT of lower extremities

523

1.75

5.98

1.1

289.85

286.19

mg/l

0.16

483

Misadventures to patients during surgical and medical care

487

1.78

5.96

1.1

1.0

303.83

289.86

mg/l

0.95

442

Diabetic neuropathy

485

1.78

5.96

1.0

1.1

304.72

278.42

mg/l

2.21

436

Undetermined asthma, excluding more controls

407

1.85

5.95

1.1

288.98

287.05

mg/l

0.08

367

Cervical disc disorders

188

1287

1.47

5.92

1.1

275.79

515.36

mg/l

0.54

173

1183

Erosion of teeth , including avohilmo

169

1133

1.50

5.92

1.1

289.31

286.04

mg/l

0.19

154

1045

Other and unspecified urticaria

120

745

1.62

5.91

1.3

1.1

284.35

291.54

mg/l

0.45

109

680

Dental pulpitis, including avohilmo

556

2844

1.25

5.88

1.1

292.65

388.67

mg/l

0.46

510

2615

Sub-endpoint used in defining T1D endpoints

161

1052

1.51

5.87

1.1

305.85

282.20

mg/l

2.84

144

970

Sulfasalazine

151

990

1.53

5.87

1.0

1.1

284.91

288.42

mg/l

0.25

140

897

Atherosclerosis, excluding cerebral and coronary sclerosis

171

897

1.50

5.87

1.1

300.80

287.84

mg/l

1.24

150

813

Major coronary heart disease event excluding revascularizations

293

1419

1.36

5.82

1.0

1.1

294.24

285.22

mg/l

1.19

270

1273

Valvular heart disease excluding rheumatic fever

229

1155

1.42

5.79

1.1

305.25

280.48

mg/l

5.18

211

1056

Other predominantly sexually transmitted diseases, not elsewhere classified

112

688

1.64

5.78

1.1

288.22

288.13

mg/l

0.00

639

Problems related to lifestyle

362

1.89

5.76

1.1

275.39

283.45

mg/l

0.42

337

Other acute lower respiratory infections

290

2046

1.35

5.74

1.1

293.14

287.26

mg/l

0.70

258

1873

Procreative management

218

1266

1.42

5.71

1.2

1.1

294.70

285.76

mg/l

0.67

195

1162

Caries of dentine, including avohilmo

405

1588

1.31

5.70

1.1

286.28

289.86

mg/l

0.43

369

1460

Peripheral artery operations in Hilmo

321

1.94

5.69

1.1

1.0

302.53

281.37

mg/l

1.03

293

Other interstitial pulmonary diseases

414

1.82

5.67

1.0

296.69

286.50

mg/l

0.58

371

Non-rheumatic valve diseases

227

1147

1.42

5.67

1.1

303.97

280.33

mg/l

4.90

209

1048

Benign neoplasm: Caecum

322

1.94

5.67

1.0

275.37

288.72

mg/l

0.87

287

Disorders of psychological development

471

1.74

5.67

1.1

287.28

281.77

mg/l

0.23

439

Anti-inflammatory and antirheumatic products, non-steroids

149

481

1.56

5.64

1.1

285.68

290.77

mg/l

0.26

136

442

Benign neoplasm: Rectum

548

1.71

5.63

1.0

1.1

290.29

289.45

mg/l

0.03

497

Other maternal disorders predominantly related to pregnancy

311

1449

1.35

5.61

1.1

306.06

503.57

mg/l

0.48

286

1318

Cerebral palsy and other paralytic syndromes

380

1.85

5.60

1.1

1.0

295.37

289.59

mg/l

0.24

346

Interstitial lung disease

416

1.81

5.59

1.0

296.69

286.30

mg/l

0.60

373

Interstitial lung disease endpoints

416

1.81

5.59

1.0

296.69

286.30

mg/l

0.60

373

Ulcerative rectosigmoiditis

296

1.97

5.59

1.1

273.61

287.11

mg/l

0.70

271

Benign neoplasm: Rectum, anus and anal canal

101

610

1.66

5.57

1.0

1.1

301.22

289.51

mg/l

0.53

556

Disorders of eyelid, lacrimal system and orbit

476

2761

1.26

5.57

1.1

292.40

396.35

mg/l

0.49

434

2522

Ovarian cyst

172

658

1.50

5.56

1.1

303.26

752.55

mg/l

0.50

155

595

Other respiratory diseases principally affecting the interstitium

483

1.75

5.55

1.0

297.21

286.46

mg/l

0.68

439

Peripheral arterial reconstruction

403

1.82

5.52

1.0

314.62

283.22

mg/l

2.23

361

Sleep disorders

522

2880

1.25

5.47

1.1

293.73

389.32

mg/l

0.46

480

2629

Undetermined asthma

419

1.80

5.45

1.1

288.98

287.82

mg/l

0.05

379

Hypocalcemia

3.00

5.44

1.1

294.74

277.31

mg/l

0.39

Cervicalgia

111

691

1.61

5.44

1.1

289.45

291.56

mg/l

0.12

103

626

Injuries to the shoulder and upper arm

487

2994

1.26

5.44

1.1

290.93

384.77

mg/l

0.48

428

2756

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

440

1.77

5.41

1.0

1.1

290.37

286.62

mg/l

0.10

403

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

307

1.94

5.39

1.1

1.0

287.16

290.93

mg/l

0.15

282

Early onset COPD

120

764

1.58

5.37

1.0

1.1

302.64

284.81

mg/l

1.90

107

692

Dental caries, including avohilmo

371

1453

1.31

5.37

1.0

1.1

284.43

290.13

mg/l

0.78

338

1332

ILD, hospital admissions

415

1.79

5.34

1.0

297.54

286.30

mg/l

0.66

373

Adverse effects, not elsewhere classified

116

735

1.59

5.30

1.1

282.11

290.86

mg/l

0.71

108

673

AV-block

365

1.78

5.29

1.0

1.1

314.36

279.93

mg/l

3.13

334

Mycoses, including avohilmo

524

3216

1.24

5.28

1.1

287.93

379.90

mg/l

0.51

477

2944

Propionic acid derivatives

147

481

1.54

5.28

1.1

286.89

290.77

mg/l

0.18

134

442

Benign neoplasm: Ascending colon

424

1.78

5.28

1.1

1.0

285.91

289.43

mg/l

0.18

383

Other arrhythmias

348

1993

1.31

5.27

1.1

1146.53

286.88

mg/l

0.50

309

1828

Emotionally unstable personality disorder

469

1.74

5.26

1.1

301.43

290.38

mg/l

0.64

437

Endometriosis

165

645

1.49

5.25

1.0

1.1

298.92

761.54

mg/l

0.51

153

583

Other arthritis (FG)

167

1147

1.46

5.23

1.1

292.54

288.69

mg/l

0.30

162

1046

Candidiasis

492

1.72

5.23

1.2

1.0

294.22

290.12

mg/l

0.19

452

Hyperparathyroidism

516

1.69

5.22

1.1

1.0

300.53

293.48

mg/l

0.46

459

ILD, hospital admissions 1, main diag only

375

1.82

5.20

1.0

294.93

288.03

mg/l

0.32

337

COPD

205

1182

1.41

5.20

1.0

1.1

297.45

286.14

mg/l

1.31

184

1064

Other and unspecified nerve root and plexus disorders, also in other diseases

123

794

1.56

5.20

1.1

1.0

288.62

285.98

mg/l

0.18

108

720

Congenital malformations, deformations and chromosomal abnormalities

344

2516

1.30

5.17

1.1

289.60

287.29

mg/l

0.19

314

2312

Metabolic disorder, other/unspecified

14.20

5.16

1.5

1.2

245.13

288.33

mg/l

—

Thyroiditis, ILD-related definition

362

1.83

5.14

1.1

1.0

314.27

293.78

mg/l

0.96

335

Ventral hernia

122

788

1.55

5.14

1.0

1.1

285.26

285.86

mg/l

0.03

114

719

Other viral diseases

176

1221

1.44

5.14

1.1

295.43

285.36

mg/l

0.61

165

1126

Visual disturbances

260

1933

1.35

5.13

1.1

289.08

289.42

mg/l

0.03

237

1761

Carpal tunnel syndrome

327

2170

1.31

5.13

1.1

293.16

292.19

mg/l

0.09

291

1970

Hernia

523

2805

1.24

5.13

1.1

291.33

392.31

mg/l

0.48

476

2566

Malignant neoplasm, including Hilmo

491

2287

1.25

5.13

1.1

296.82

413.64

mg/l

0.45

449

2098

Peripheral artery disease

185

1021

1.43

5.11

1.1

1.0

296.71

286.35

mg/l

0.93

160

922

Other disorders of bone

117

750

1.57

5.11

1.1

290.44

286.79

mg/l

0.14

103

689

Diseases of middle ear and mastoid

327

2045

1.31

5.10

1.1

1150.83

286.85

mg/l

0.50

309

1874

Thyrotoxicosis, other and/or unspecified

107

672

1.60

5.09

1.0

1.1

301.06

294.88

mg/l

0.38

611

Retention of urine

155

849

1.48

5.06

1.1

286.70

286.26

mg/l

0.03

138

775

Moderate visual impairment, binocular

3.30

5.03

1.0

1.1

316.28

288.10

mg/l

1.07

Insomnia

513

2884

1.24

5.03

1.1

294.51

389.64

mg/l

0.46

476

2634

Assault

590

1.64

5.01

1.1

293.38

279.18

mg/l

0.97

547

Adjustment and management of implanted device

432

1.74

4.97

1.1

318.86

284.19

mg/l

2.93

394

Impingement syndrome of shoulder

128

844

1.52

4.93

1.0

1.1

2577.58

286.66

mg/l

0.50

116

767

Epilepsy

158

1085

1.46

4.90

1.1

283.65

286.12

mg/l

0.16

147

997

Mixed specific developmental disorders

2.98

4.87

1.2

1.1

280.29

283.70

mg/l

0.05

Eating disorders

361

1.81

4.86

1.1

298.07

296.69

mg/l

0.04

335

Mixed and other personality disorders

306

1.88

4.79

1.1

297.14

287.10

mg/l

0.71

282

Decubitus ulcer and pressure area

163

2.22

4.78

1.0

308.35

280.58

mg/l

1.21

144

Other viral diseases, including avohilmo

229

1673

1.36

4.78

1.1

293.83

286.39

mg/l

0.54

217

1544

Spondylosis

272

1601

1.33

4.78

1.1

285.53

472.85

mg/l

0.52

246

1471

475

1.69

4.78

1.0

1.1

306.88

289.41

mg/l

0.62

435

Primary hyperparathyroidism

328

1.84

4.76

1.0

299.37

291.84

mg/l

0.39

293

Dilated cardiomyopathy

357

1.80

4.75

1.0

1.1

306.63

282.96

mg/l

1.43

325

Acute bronchitis

208

1484

1.38

4.74

1.1

293.10

288.18

mg/l

0.43

183

1345

Alzheimer disease, including avohilmo

627

0.53

4.70

1.0

296.12

292.73

mg/l

0.11

551

Migraine with aura and triptan purchases

608

1.60

4.69

1.1

291.00

296.27

mg/l

0.26

561

Trigger finger

501

1.66

4.67

1.0

1.1

299.39

288.73

mg/l

0.60

455

COPD (mode)

137

718

1.49

4.66

1.0

1.1

304.46

285.36

mg/l

2.13

123

639

Conduction disorders

134

719

1.50

4.65

1.0

1.1

300.11

285.26

mg/l

1.54

123

655

Personal history of other diseases and conditions

409

1.74

4.65

1.1

299.34

295.63

mg/l

0.14

380

Volume depletion

218

2.03

4.65

1.1

316.43

282.28

mg/l

1.49

189

Malignant neoplasm, wide definition

487

2293

1.24

4.64

1.1

297.54

413.24

mg/l

0.44

447

2103

Mycoses

152

1052

1.45

4.63

1.1

298.45

286.81

mg/l

1.15

141

960

Nonorganic sleeping disorders

133

897

1.49

4.63

1.1

291.32

288.25

mg/l

0.15

121

829

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

129

865

1.50

4.62

1.1

284.69

286.88

mg/l

0.12

114

804

Liquid cancers

141

909

1.47

4.62

1.1

1.0

308.53

286.85

mg/l

2.60

129

828

Lichen ruber planus, wide definition including periferal and oral lichen planus

120

793

1.52

4.61

1.1

294.91

290.39

mg/l

0.29

110

720

Spinal stenosis

236

1289

1.35

4.60

1.1

290.02

518.37

mg/l

0.51

209

1177

Osteoporosis

120

727

1.52

4.59

1.0

1.1

306.49

296.80

mg/l

0.74

105

646

Injuries to the wrist and hand

571

3124

1.21

4.58

1.1

809.74

288.89

mg/l

0.51

516

2870

Benign neoplasm: Sigmoid colon

589

1.60

4.56

1.1

1.0

281.83

287.97

mg/l

0.41

535

Infections with a predominantly sexual mode of transmission, including avohilmo

241

1650

1.34

4.55

1.1

292.11

287.81

mg/l

0.30

212

1525

Colonic or urogenital fistula

146

1007

1.45

4.54

1.1

297.94

286.99

mg/l

0.63

127

920

Diseases of pulp and periapical tissues and dental caries

327

1294

1.30

4.52

1.0

1.1

285.36

289.04

mg/l

0.39

299

1186

Fracture of lower leg, including ankle

301

2286

1.29

4.52

1.1

286.56

415.12

mg/l

0.51

279

2098

Other enthesopathies

163

1149

1.42

4.50

1.0

1.1

2082.62

291.58

mg/l

0.49

148

1048

Disorders resulting from impaired renal tubular function

117

2.42

4.49

1.0

1.1

276.50

281.30

mg/l

0.14

105

Special screening examination for neoplasms

168

2.16

4.46

1.1

282.42

292.32

mg/l

0.26

151

Polymyalgia rheumatica

328

1.81

4.45

1.1

1.0

308.60

288.73

mg/l

1.22

290

Thyrotoxicosis

133

908

1.47

4.38

1.0

1.1

298.81

295.53

mg/l

0.20

124

818

Diseases of external ear

184

1332

1.39

4.38

1.1

291.09

287.58

mg/l

0.26

164

1210

Other disorders of patella

103

667

1.55

4.37

1.0

1.1

295.54

290.80

mg/l

0.32

610

Mixed connective tissue disease

3.39

4.34

1.1

1.0

270.53

299.15

mg/l

0.75

Allergic asthma (mode), excluding more controls

125

824

1.48

4.32

1.0

1.1

288.10

284.10

mg/l

0.26

115

757

Other and unspecified drugs and medicaments

288

1.85

4.32

1.1

292.62

291.94

mg/l

0.02

260

Other specified/unspecified arthritis

143

993

1.44

4.31

1.1

295.33

291.55

mg/l

0.27

138

900

Convalescence

164

2.15

4.31

1.0

293.33

288.03

mg/l

0.17

153

Triptan medication for migraine, min. 3 purchases

331

1941

1.28

4.31

1.1

287.75

294.70

mg/l

1.00

311

1778

Other arthrosis

282

1449

1.31

4.31

1.1

286.22

491.25

mg/l

0.51

247

1320

Other pleural conditions

274

1.87

4.30

1.0

303.42

286.19

mg/l

0.83

244

Schizophrenia or delusion

182

1322

1.38

4.26

1.1

287.40

283.73

mg/l

0.29

169

1210

Migraine without aura and triptan purchases

101

656

1.55

4.24

1.1

285.47

297.49

mg/l

0.97

607

Alzheimer disease

541

0.51

4.23

1.0

284.72

292.96

mg/l

0.30

479

Other skin changes

641

1.55

4.21

1.1

1.0

286.76

290.72

mg/l

0.24

578

Redundant prepuce, phimosis and paraphimosis

130

877

1.46

4.20

1.2

1.1

269.42

270.34

mg/l

0.06

122

817

Internal derangement of knee

204

1497

1.35

4.19

1.1

289.78

484.09

mg/l

0.50

178

1365

Acute suppurative otitis media

161

1069

1.41

4.19

1.1

293.03

282.43

mg/l

0.76

152

996

Disorders of tooth development and eruption

493

1.57

4.18

1.1

298.70

286.52

mg/l

0.61

464

Schizophrenia, schizotypal and delusional disorders

182

1327

1.38

4.17

1.1

287.40

283.63

mg/l

0.30

169

1215

Other chronic obstructive pulmonary disease

189

1130

1.37

4.15

1.0

1.1

299.82

286.94

mg/l

1.49

168

1014

Pervasive developmental disorders excl. Autism + Asperger

3.43

4.12

1.1

264.79

287.50

mg/l

0.38

Haemorrhoids and perianal venous thrombosis

154

1086

1.41

4.11

1.1

281.13

289.18

mg/l

0.82

144

987

Fracture of foot, except ankle

144

1012

1.43

4.10

1.1

282.83

286.23

mg/l

0.22

135

927

Suppurative and unspecified otitis media

208

1372

1.35

4.09

1.1

290.36

284.54

mg/l

0.43

198

1269

Other abnormal findings of blood chemistry

135

2.24

4.09

1.1

281.03

284.66

mg/l

0.11

120

Pain in thoracic spine

520

1.60

4.08

1.0

1.1

271.18

290.09

mg/l

2.15

473

Atopic dermatitis, strict definition

177

1264

1.37

4.01

1.0

1.1

297.75

289.11

mg/l

0.80

169

1168

DVT of lower extremities and pulmonary embolism

189

1389

1.36

4.01

1.1

303.81

287.59

mg/l

1.94

170

1259

UC patients in KELA-register (code 208), prior to 1994

143

2.19

4.00

1.1

304.35

286.63

mg/l

0.56

131

Allergic asthma (mode)

125

840

1.46

3.96

1.0

1.1

288.10

285.10

mg/l

0.18

115

771

Vasomotor and allergic rhinitis

208

1527

1.33

3.93

1.1

290.58

289.83

mg/l

0.05

186

1419

All influenza

133

929

1.44

3.92

1.2

1.1

293.32

283.00

mg/l

0.86

119

849

Drug-induced osteoporosis with pathological fracture

4.13

3.92

1.0

1.1

315.54

296.59

mg/l

0.47

Liquid cancers, including Hilmo

169

1082

1.38

3.92

1.1

305.40

287.11

mg/l

2.20

154

983

Other problems related to primary support group, including family circumstances

421

1.65

3.90

1.0

1.1

4311.14

290.44

mg/l

0.49

386

Myocardial infarction, without ST-elevation

161

1048

1.39

3.90

1.0

1.1

299.39

286.95

mg/l

1.22

146

946

Paracetamol or NSAID medication

286

1.59

3.84

1.1

286.38

282.36

mg/l

0.15

267

Heartburn

307

1.77

3.84

1.0

1.1

284.31

287.50

mg/l

0.17

277

Chondropathies

577

1.55

3.81

1.1

288.13

287.46

mg/l

0.02

533

Diseases of tongue

166

2.06

3.80

1.1

281.94

289.11

mg/l

0.18

155

Disorders of vestibular function (Vertigo)

225

1674

1.31

3.79

1.1

290.62

292.76

mg/l

0.18

201

1513

Disease of hard tissues of teeth, NOS

255

1025

1.30

3.76

1.1

1.0

285.46

289.30

mg/l

0.36

231

952

Other diseases of the respiratory system

563

1.55

3.75

1.1

1.0

306.58

286.15

mg/l

1.57

510

Other respiratory disorders and diseases

563

1.55

3.75

1.1

1.0

306.58

286.15

mg/l

1.57

510

Other female pelvic inflammatory diseases

508

1.58

3.75

1.0

1.1

301.72

299.64

mg/l

0.10

456

Noninflammatory disorders of female genital tract

184

675

1.37

3.75

1.0

1.1

306.81

739.98

mg/l

0.50

164

612

Alzheimer’s disease, strict definition

455

0.48

3.73

1.0

287.48

296.08

mg/l

0.27

406

Other cataract

211

1184

1.33

3.73

1.0

1.1

289.92

291.78

mg/l

0.15

192

1076

COPD related to multimorbidity

166

1024

1.37

3.73

1.0

1.1

296.14

285.93

mg/l

1.00

147

919

Other sleep disorders

370

1.68

3.72

1.1

278.79

287.67

mg/l

0.49

342

Oter anti-inflammatory and antirheumatic agents, non-steroids

316

1.57

3.69

1.1

1.0

278.76

300.75

mg/l

2.05

287

Status post-ami

102

516

1.50

3.68

1.0

1.1

297.35

283.83

mg/l

0.98

457

Unspecified fall

266

2049

1.28

3.66

1.1

287.64

287.82

mg/l

0.01

244

1874

Polyuria

101

681

1.49

3.62

1.1

278.52

286.36

mg/l

0.49

620

Fall on and from stairs and steps

137

979

1.40

3.60

1.1

289.31

287.70

mg/l

0.10

125

892

Striking against or struck by other objects

198

1497

1.32

3.60

1.1

282.88

281.15

mg/l

0.12

179

1385

Metatarsalgia

315

1.72

3.54

1.0

1.1

296.21

291.56

mg/l

0.19

287

Haemolytic anaemias

2.35

3.51

1.1

306.09

290.51

mg/l

0.36

Solid cancers, including Hilmo

464

2248

1.20

3.50

1.1

295.55

416.00

mg/l

0.46

426

2060

Other and unspecified rosacea

324

1.71

3.49

1.1

1.0

283.48

293.25

mg/l

0.26

297

Mouth breathing

211

1619

1.30

3.47

1.0

1.1

289.05

283.14

mg/l

0.57

195

1477

Agranulocytosis

363

1.66

3.45

1.1

1.0

334.33

292.09

mg/l

1.65

329

Other enthesopathy of foot (+metatarsalgia)

348

1.67

3.44

1.1

296.87

290.99

mg/l

0.27

316

Lichen planus, including avohilmo

657

1.48

3.42

1.1

297.45

290.61

mg/l

0.40

594

Migraine, single triptan purchase ok & required. ICD-code if available is included

439

2472

1.20

3.41

1.0

1.1

283.51

408.09

mg/l

0.54

405

2266

Triptan medication for migraine, single purchase ok

439

2472

1.20

3.41

1.0

1.1

283.51

408.09

mg/l

0.54

405

2266

Otitis externa

122

865

1.41

3.38

1.1

294.41

287.04

mg/l

0.56

111

786

Alzheimer’s disease (Late onset)

391

0.46

3.38

1.0

298.88

297.09

mg/l

0.04

347

Other embolism and thrombosis

381

1.63

3.37

1.1

1.0

298.89

290.36

mg/l

0.38

349

Other specified and unspecified personality disorders

328

1.69

3.35

1.1

303.14

288.08

mg/l

0.82

302

Degeneration of macula and posterior pole

195

1144

1.32

3.35

1.1

289.80

292.78

mg/l

0.22

179

1016

Subjective visual disturbances

135

978

1.38

3.31

1.1

287.25

291.20

mg/l

0.28

122

890

Malignant neoplasm

458

2241

1.20

3.31

1.1

297.31

416.42

mg/l

0.45

415

2054

Viral and other specified intestinal infections, including avohilmo

156

1112

1.35

3.31

1.2

1.1

297.50

282.14

mg/l

1.24

144

1027

Vitreous haemorrhage

337

1.67

3.31

1.1

1.0

311.93

289.75

mg/l

1.37

309

Diseases of inner ear

260

1976

1.26

3.28

1.1

292.52

291.28

mg/l

0.10

232

1795

Assault by bodily force

323

1.68

3.27

1.1

283.54

277.66

mg/l

0.23

299

Monoamine oxidase A inhibitors

338

1.66

3.27

1.2

1.0

286.16

289.21

mg/l

0.15

313

Other contact dermatitis

278

1.74

3.26

1.0

304.02

290.51

mg/l

0.42

252

Other salmonella infections

109

2.22

3.26

1.1

1.0

311.96

282.89

mg/l

1.29

Pulmonary heart disease, diseases of pulmonary circulation

137

998

1.38

3.25

1.1

317.36

285.97

mg/l

4.63

127

899

Deviated nasal septum

164

1229

1.34

3.22

1.0

1.1

272.42

282.80

mg/l

1.16

146

1135

Phlebitis and thrombophlebitis (not including DVT)

105

732

1.44

3.22

1.1

1.0

290.26

290.21

mg/l

0.00

670

Other spirochaetal diseases, including avohilmo

179

1362

1.32

3.20

1.1

295.97

290.76

mg/l

0.37

161

1234

Colectomy operation

505

1.53

3.19

1.1

1.0

297.88

288.64

mg/l

0.44

459

Any event in cancer register

494

2437

1.18

3.17

1.1

296.53

406.45

mg/l

0.45

449

2241

COPD, hospital admissions 1, only main diagnosis

134

837

1.38

3.17

1.0

1.1

300.41

285.39

mg/l

1.54

118

761

COPD, hospital admission 2, with asthma infections

127

788

1.39

3.16

1.0

1.1

310.37

285.12

mg/l

3.32

112

712

Nonsuppurative otitis media, including avohilmo

176

1155

1.32

3.14

1.1

293.02

284.26

mg/l

0.74

165

1065

Other spirochaetal diseases

177

1350

1.31

3.12

1.1

296.86

291.14

mg/l

0.41

159

1225

Temporomandibular joint disorders, including avohilmo

246

1894

1.26

3.11

1.0

1.1

292.91

294.05

mg/l

0.08

220

1730

Inflammatory diseases of prostate (prostatitis)

422

1.57

3.08

1.0

1.1

255.66

276.41

mg/l

2.07

388

Pericarditis

112

2.16

3.07

1.0

1.1

302.17

273.75

mg/l

1.10

104

Malignant neoplasm

456

2250

1.19

3.04

1.1

297.78

415.88

mg/l

0.44

413

2062

Single ventricle heart

10.79

3.03

1.0

300.00

267.40

mg/l

—

Injuries to the neck

127

926

1.38

3.03

1.0

1.1

280.49

287.06

mg/l

0.44

118

851

Other salmonella infections, including avohilmo

133

2.05

3.02

1.1

1.0

308.22

285.97

mg/l

0.95

119

Diseases of male genital organs

286

1157

1.25

3.01

1.1

267.86

273.10

mg/l

0.66

268

1076

Disorders of sclera, cornea, iris and ciliary body

287

2333

1.23

3.01

1.1

288.13

287.73

mg/l

0.03

265

2130

Diabetic retinopathy, excluding more controls

172

727

1.33

2.99

1.0

1.1

299.76

281.35

mg/l

2.29

156

654

Endometriosis of ovary

528

1.48

2.99

1.0

1.1

301.67

307.81

mg/l

0.34

478

Tic and related disorders

3.89

2.98

1.1

1.2

258.50

280.38

mg/l

—

Ethmoidectomy

482

1.52

2.97

1.2

1.1

284.37

287.73

mg/l

0.16

443

Lyme disease

174

1335

1.31

2.96

1.1

295.21

291.17

mg/l

0.26

156

1212

Lyme disease, including avohilmo

174

1335

1.31

2.96

1.1

295.21

291.17

mg/l

0.26

156

1212

Mental and behavioural disorders due to opioids

148

1.98

2.95

1.1

313.69

272.44

mg/l

2.25

136

Pollen allergy

115

817

1.39

2.95

1.1

287.47

287.82

mg/l

0.02

102

762

Viral infections characterized by skin and mucous membrane lesions

219

1730

1.27

2.94

1.1

291.84

286.82

mg/l

0.33

207

1573

Deforming dorsopathies

135

999

1.35

2.94

1.1

297.39

292.91

mg/l

0.20

120

913

Spirochaetal infections, other/unspecified, including avohilmo

175

1347

1.30

2.92

1.1

295.81

291.11

mg/l

0.32

157

1220

Viral warts

366

1.59

2.89

1.1

301.64

290.15

mg/l

0.24

336

Fentanyl

228

1.76

2.88

1.1

311.12

291.95

mg/l

0.65

206

Rheumatoid arthritis

151

1008

1.33

2.87

1.1

291.97

587.36

mg/l

0.50

139

906

Unspecific neurodegenerative disorder

766

0.68

2.85

1.0

295.15

294.78

mg/l

0.01

678

Other degenerative diseases of the nervous system

111

579

1.40

2.85

1.0

1.1

276.99

295.40

mg/l

2.12

104

525

Other neurological diseases

343

2207

1.21

2.84

1.1

281.19

291.22

mg/l

2.00

313

1997

Respiratory insufficiency

185

1.84

2.84

1.1

1.0

311.34

281.49

mg/l

1.32

163

Angina pectoris

251

1336

1.25

2.82

1.1

288.94

285.73

mg/l

0.27

231

1201

Venous thromboembolism

244

1890

1.24

2.82

1.1

302.53

288.92

mg/l

1.93

219

1715

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

217

1702

1.26

2.81

1.1

289.13

287.05

mg/l

0.16

204

1567

Childhood asthma (age<16), excluding more controls

385

1.51

2.80

1.1

286.04

275.85

mg/l

0.34

359

COPD, early/later onset

189

1237

1.28

2.79

1.0

1.1

299.82

287.58

mg/l

1.39

168

1114

Persons encountering health services in circumstances related to reproduction

335

1860

1.21

2.79

1.1

287.43

442.63

mg/l

0.50

308

1708

Psychotic depression

173

1.86

2.76

1.1

289.85

287.43

mg/l

0.07

164

Sequelae of injuries, of poisoning and of other consequences of external causes

127

942

1.35

2.76

1.1

300.65

283.64

mg/l

1.87

118

863

Faecal incontinence

210

1.77

2.74

1.0

300.69

294.49

mg/l

0.23

185

severe traumatic brain injury, does not include concussion

664

1.42

2.74

1.1

276.97

283.29

mg/l

0.37

604

Disorders of phosphorus metabolism and phosphatases

6.15

2.72

1.0

1.1

265.83

294.70

mg/l

—

Vestibular neuronitis

294

1.64

2.71

1.0

284.57

290.61

mg/l

0.25

271

Calculus of kidney and ureter

136

1023

1.33

2.70

1.1

276.33

283.02

mg/l

0.54

123

936

Childhood asthma (age<16)

389

1.49

2.68

1.1

286.04

276.75

mg/l

0.30

363

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

642

1.42

2.68

1.0

1.1

309.83

299.60

mg/l

0.67

579

COPD, hospital admissions

186

1227

1.28

2.68

1.0

1.1

299.63

287.20

mg/l

1.41

167

1102

Periapical abscess

248

2014

1.23

2.68

1.1

287.07

286.97

mg/l

0.01

228

1841

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

485

3248

1.16

2.66

1.1

290.33

379.00

mg/l

0.49

453

2966

Allergic urticaria

288

1.64

2.66

1.1

1.0

280.93

293.89

mg/l

0.60

262

Viral and other specified intestinal infections

113

808

1.37

2.66

1.2

1.1

292.26

283.37

mg/l

0.52

104

741

Complications of internal orthopaedic prosthetic devices, implants and grafts

660

1.41

2.65

1.0

295.38

289.71

mg/l

0.33

592

446

1.49

2.64

1.0

283.27

295.90

mg/l

0.70

392

Other/unspecified enthesopathies of lower limb, excluding foot

258

1.68

2.64

1.0

1.1

286.89

290.55

mg/l

0.14

237

Carcinoma in situ of skin of trunk

2.41

2.63

1.0

291.31

291.93

mg/l

0.01

Pain associated with micturition

391

1.54

2.63

1.0

275.86

292.81

mg/l

1.15

355

Tongue abnormality

191

1.79

2.62

1.1

1.0

281.94

288.11

mg/l

0.15

169

Pre-eclampsia or eclampsia

108

789

1.37

2.61

1.1

1.0

293.27

303.29

mg/l

0.72

705

603

1.40

2.60

1.0

282.65

295.94

mg/l

1.00

530

Superficial injury of thorax

531

1.45

2.58

1.0

285.28

286.05

mg/l

0.03

485

Necrosis of pulp, including avohilmo

323

2671

1.20

2.57

1.1

289.62

287.18

mg/l

0.24

289

2464

Nonsuppurative otitis media

125

810

1.34

2.57

1.1

299.12

284.54

mg/l

1.17

117

744

Other inflammation of eyelid, including avohilmo

243

1979

1.23

2.57

1.1

292.08

290.83

mg/l

0.09

220

1808

Stroke, excluding SAH

261

1538

1.23

2.57

1.1

289.47

290.43

mg/l

0.08

232

1392

Pure hyperglyceridaemia

2.38

2.56

1.1

274.13

279.59

mg/l

0.14

Cardiomyopathy in other diseases

5.57

2.56

1.0

270.17

316.82

mg/l

—

Lichen planus

427

1.50

2.53

1.0

294.12

293.47

mg/l

0.02

386

Dermatopolymyositis

3.26

2.53

1.0

1.1

304.00

280.15

mg/l

—

Lung diseases due to external agents

379

1.53

2.52

1.1

293.53

285.87

mg/l

0.28

345

Stroke, including SAH

282

1669

1.21

2.52

1.1

287.86

290.09

mg/l

0.21

253

1509

Viral pneumonia

428

1.50

2.50

1.1

309.60

288.35

mg/l

0.67

391

Other inflammation of eyelid

518

1.45

2.50

1.1

294.94

291.63

mg/l

0.13

466

Pregnancy hypertension

204

1459

1.25

2.50

1.1

292.07

302.76

mg/l

1.26

192

1319

Supplementary factors related to causes of morbidity and mortality classified elsewhere

160

1246

1.29

2.50

1.1

290.87

285.59

mg/l

0.36

148

1140

FESS (DNB20)

470

1.47

2.48

1.2

1.1

282.92

287.71

mg/l

0.23

431

Myocardial infarction

211

1183

1.25

2.45

1.0

1.1

295.66

284.38

mg/l

1.28

195

1068

Lesion of lateral popliteal nerve

159

1.84

2.44

1.2

1.1

290.38

284.09

mg/l

0.20

146

Primary_lymphoid and hematopoietic malignant neoplasms

100

732

1.37

2.41

1.1

310.11

285.53

mg/l

2.19

659

Medical abortion

296

1329

1.21

2.41

1.1

304.23

301.71

mg/l

0.22

266

1198

Hypermobility syndrome

167

1.81

2.41

1.1

1.0

261.63

305.33

mg/l

2.86

153

Spirochaetal infections, other/unspecified

312

1.58

2.41

1.1

1.0

287.93

288.75

mg/l

0.03

282

Other obstetric conditions, not elsewhere classified

162

795

1.29

2.40

1.0

1.1

299.58

303.32

mg/l

0.24

157

734

Insulin, fast-acting (human)

523

1.44

2.39

1.2

1.1

327.25

280.40

mg/l

3.92

484

Open wound of lower leg

523

1.44

2.39

1.0

1.1

297.18

288.02

mg/l

0.50

479

Sequelae of cerebrovascular disease

141

926

1.30

2.39

1.0

1.1

289.27

290.97

mg/l

0.10

128

832

Congenital malformations of cardiac chambers and connections

4.21

2.38

1.0

1.2

364.43

326.18

mg/l

—

Motor disorders, excluding more controls

2.90

2.37

1.1

1.2

278.09

260.71

mg/l

0.31

Postprocedural disorders of digestive system, not elsewhere classified

2.08

2.37

1.1

1.0

278.70

282.70

mg/l

0.10

Tic disorders

3.07

2.36

1.1

258.50

290.29

mg/l

—

Familial hypercholesterolemia, with ischemic heart disease

213

1.70

2.35

1.0

298.19

290.90

mg/l

0.23

188

Car occupant injured in other and unspecified transport accidents

104

770

1.35

2.35

1.1

280.76

287.13

mg/l

0.40

711

Cervicobrachial syndrome

107

796

1.35

2.34

1.1

279.59

292.04

mg/l

1.17

101

723

Complications predominantly related to the puerperium

126

961

1.31

2.33

1.0

1.1

296.49

301.82

mg/l

0.38

119

863

Polyarthrosis

624

1.37

2.32

1.1

1.0

293.30

297.45

mg/l

0.20

559

Pre-eclampsia or poor fetal growth

147

1140

1.29

2.32

1.1

290.11

303.32

mg/l

1.47

137

1027

Other chronic obstructive pulmonary disease, including avohilmo

232

1559

1.22

2.31

1.0

1.1

1573.16

287.20

mg/l

0.50

208

1415

Rosacea

469

1.46

2.31

1.1

1.0

289.46

293.95

mg/l

0.13

429

Other disorders of veins

190

1502

1.25

2.31

1.0

1.1

303.93

489.07

mg/l

0.47

164

1367

Urolithiasis

142

1102

1.29

2.31

1.1

277.66

283.72

mg/l

0.46

128

1009

Fall on same level involving ice and snow

295

2478

1.19

2.29

1.1

294.92

407.08

mg/l

0.47

267

2257

Postmenopausal bleeding

116

452

1.35

2.29

1.1

305.79

963.17

mg/l

0.50

104

405

Superficial injury of wrist and hand

118

895

1.32

2.28

1.1

296.55

283.54

mg/l

1.17

108

830

Complex cardiac defects

3.98

2.27

1.0

1.1

364.43

282.28

mg/l

—

Soft tissue disorders related to use, overuse and pressure

128

983

1.30

2.26

1.1

290.53

290.78

mg/l

0.01

113

893

Later onset COPD, excluding more controls

344

1.46

2.25

1.1

1.0

292.83

283.26

mg/l

0.40

301

Benign neoplasm: other/unspecified salivary gland

0.00

2.25

0.0

1.1

—

292.96

—

Achilles tendinitis

366

1.51

2.24

1.1

1.0

275.91

286.75

mg/l

0.59

338

Stomatitis and related lesions

100

742

1.35

2.24

1.1

283.55

288.55

mg/l

0.30

676

Localized swelling, mass and lump of skin and subcutaneous tissue

154

1213

1.27

2.24

1.1

293.74

290.82

mg/l

0.20

144

1096

Disorders of conjunctiva

447

3008

1.15

2.23

1.1

291.76

386.07

mg/l

0.48

407

2756

Unstable angina pectoris

138

840

1.29

2.21

1.1

291.98

285.07

mg/l

0.51

129

748

Use of memantine

468

0.62

2.21

1.0

300.55

293.94

mg/l

0.19

415

Use of other anti-dementia drugs

468

0.62

2.21

1.0

300.55

293.94

mg/l

0.19

415

Non-allergic asthma (mode), excluding more controls

553

1.40

2.18

1.0

1.1

314.49

286.31

mg/l

1.30

498

Use of anticholinesterases

652

0.68

2.18

1.0

294.27

293.27

mg/l

0.03

578

N06DA Anticholinesterases

652

0.68

2.18

1.0

294.27

293.27

mg/l

0.03

578

Solid cancers

432

2193

1.16

2.17

1.1

295.76

419.66

mg/l

0.46

391

2007

Other viral diseases, not elsewhere classified, including avohilmo

146

1143

1.27

2.13

1.1

289.40

286.82

mg/l

0.11

141

1052

Cardiodefibrillation

138

1077

1.28

2.12

1.1

2353.01

285.00

mg/l

0.50

130

970

Other maltreatment syndromes

123

1.89

2.12

1.1

302.13

276.79

mg/l

0.70

116

Benign paroxysmal vertigo

128

994

1.29

2.10

1.0

1.1

297.90

293.63

mg/l

0.31

115

898

Seropositive rheumatoid arthritis

108

815

1.32

2.10

1.0

1.1

293.39

294.77

mg/l

0.06

737

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

144

1123

1.27

2.08

1.0

1.1

2258.34

293.65

mg/l

0.49

135

1039

Rheumatoid arthritis, including avohilmo

170

1371

1.24

2.05

1.1

291.54

294.01

mg/l

0.17

157

1236

Viral warts, including avohilmo

118

911

1.30

2.04

1.1

297.59

285.89

mg/l

0.50

106

838

Endometriosis ASRM stages 3,4

104

789

1.32

2.04

1.0

1.1

298.83

298.63

mg/l

0.01

715

Keratitis

178

1444

1.23

2.04

1.1

289.22

287.21

mg/l

0.14

164

1316

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

302

1.53

2.03

1.1

293.23

291.20

mg/l

0.06

274

Diabetic nephropathy

712

1.34

2.02

1.1

321.32

283.09

mg/l

4.80

644

Pre-eclampsia

739

1.33

2.01

1.1

295.97

303.25

mg/l

0.44

661

Dermatopolymyositis (FG)

2.66

2.01

1.0

1.1

304.00

292.48

mg/l

—

Tic and related disorders

2.66

2.01

1.1

258.50

290.12

mg/l

—

Superficial injury of shoulder and upper arm

434

1.43

2.00

1.1

1.0

292.87

284.88

mg/l

0.38

400

Diabetes mellitus in pregnancy

162

823

1.25

1.99

1.0

1.1

312.05

302.98

mg/l

0.75

150

767

Diabetic nephropathy, excluding more controls

573

1.34

1.98

1.1

324.00

282.00

mg/l

5.57

512

Conjunctivitis

406

2855

1.15

1.93

1.1

292.64

391.97

mg/l

0.48

372

2613

Open wound of forearm

347

1.48

1.91

1.1

300.91

285.30

mg/l

0.75

315

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

154

775

1.25

1.91

1.0

1.1

298.32

303.41

mg/l

0.33

149

714

Fitting and adjustment of other devices

145

1019

1.25

1.91

1.1

284.80

288.61

mg/l

0.29

137

921

Asthma/COPD (KELA code 203)

494

2919

1.13

1.90

1.1

290.73

387.32

mg/l

0.48

446

2674

Haemorrhage in early pregnancy

131

1006

1.27

1.89

1.1

298.34

302.13

mg/l

0.25

119

908

Bitten or struck by other mammals

439

1.42

1.89

1.0

1.1

284.96

291.28

mg/l

0.23

401

Assault by blunt object

2.33

1.88

1.2

1.1

262.25

277.91

mg/l

0.34

Myocardial infarction, strict

186

1078

1.22

1.88

1.0

1.1

299.13

282.80

mg/l

2.01

171

974

Other diseases of blood and blood-forming organs

236

1.58

1.87

1.0

1.1

311.09

287.90

mg/l

1.07

212

Need for other prophylactic measures

205

1.62

1.86

1.1

1.0

317.18

280.19

mg/l

0.94

186

Benign neoplasm: Pancreas

1.99

1.85

1.0

286.76

292.66

mg/l

0.11

Superficial injury of abdomen, lower back and pelvis

568

1.36

1.85

1.1

300.72

286.68

mg/l

0.76

521

Multiple myeloma

2.22

1.84

1.1

1.0

297.62

284.28

mg/l

0.22

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.22

1.84

1.1

1.0

297.62

284.28

mg/l

0.22

Other and unspecified tonsillitis

184

1258

1.22

1.83

1.1

286.25

281.79

mg/l

0.25

166

1171

Disorders of adrenal gland, other and/or unspecified

4.24

1.83

1.0

306.00

292.83

mg/l

—

Oxicams

372

1.35

1.83

1.1

1.0

280.36

294.96

mg/l

1.04

338

Arthrosis

350

1659

1.16

1.83

1.0

1.1

279.32

465.37

mg/l

0.54

315

1517

Pregnancy examination and test

365

1.36

1.82

1.1

301.68

312.51

mg/l

0.57

336

Diseases of appendix

386

3026

1.14

1.79

1.1

290.22

384.11

mg/l

0.49

353

2776

Non-allergic asthma (mode)

575

1.35

1.78

1.0

1.1

314.49

286.95

mg/l

1.26

519

Contraceptive management

232

1365

1.19

1.78

1.1

290.92

501.87

mg/l

0.50

216

1258

Thyrotoxicosis with toxic multinodular goitre

161

1.68

1.78

1.0

301.07

293.88

mg/l

0.22

138

Allergic rhinitis

168

1361

1.22

1.77

1.1

287.39

289.13

mg/l

0.11

151

1257

Follicular cysts of skin and subcutaneous tissue

668

1.32

1.77

1.1

288.12

283.25

mg/l

0.28

608

Spondylolisthesis/Spondylolysis

608

1.34

1.76

1.1

286.32

292.28

mg/l

0.29

549

All influenza (not pneumonia)

548

1.35

1.75

1.2

1.1

289.67

286.28

mg/l

0.14

503

All dysplastic lesions of the vagina

2.04

1.75

1.0

1.1

315.20

295.95

mg/l

0.63

Fracture of skull and facial bones

108

844

1.28

1.75

1.1

278.52

282.62

mg/l

0.24

100

772

COPD-related respiratory insufficiency

305

1.48

1.74

1.1

1.0

303.83

286.29

mg/l

0.92

274

Tonsillectomy and adenotomy

313

1882

1.16

1.74

1.1

290.67

286.89

mg/l

0.39

289

1735

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

217

1586

1.19

1.70

1.1

291.31

488.74

mg/l

0.54

204

1431

Disorders of vitreous body

229

1847

1.18

1.69

1.1

301.78

451.27

mg/l

0.46

196

1672

Leiomyoma of uterus

291

1403

1.16

1.69

1.1

301.67

512.68

mg/l

0.50

265

1265

Superficial injury of hip and thigh

475

1.37

1.68

1.1

1.0

283.02

288.82

mg/l

0.25

431

Abscess of anal and rectal regions

284

1.48

1.66

1.0

1.1

297.81

286.46

mg/l

0.19

260

Retinal detachments and breaks

144

1173

1.23

1.65

1.1

291.58

286.77

mg/l

0.35

132

1057

Hypoparathyroidism

1.90

1.65

1.0

315.88

289.58

mg/l

0.95

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

244

1.52

1.65

1.1

1.0

287.69

293.25

mg/l

0.18

219

Other and unspecified epidermal thickening

2.04

1.65

1.0

1.1

291.50

283.55

mg/l

0.13

Other benign neoplasms of skin

162

1337

1.21

1.64

1.1

291.96

291.73

mg/l

0.01

141

1210

Dislocation, sprain and strain of joints and ligaments at neck level

625

1.32

1.63

1.0

1.1

281.72

290.56

mg/l

0.44

572

Burns and corrosions of external body surface, specified by site

419

1.39

1.62

1.0

1.1

291.08

283.55

mg/l

0.31

388

Other specified disorders of external ear

131

0.38

1.62

1.0

1.1

334.80

288.86

mg/l

—

122

Radiculopathy

453

1.37

1.62

1.0

1.1

293.75

290.27

mg/l

0.12

411

Disorders of vitreous body and globe

233

1880

1.17

1.61

1.1

302.75

448.48

mg/l

0.45

200

1702

Slow fetal growth and fetal malnutrition

3.60

1.61

1.0

1.1

310.20

295.00

mg/l

—

Other superficial mycoses, including avohilmo

420

1.39

1.60

1.1

293.35

285.69

mg/l

0.28

384

Diabetic retinopathy, strict definition

102

711

1.28

1.60

1.0

1.1

311.45

283.83

mg/l

2.65

643

Appendicitis, broad definition

380

3014

1.13

1.59

1.1

290.66

384.30

mg/l

0.48

348

2766

Sensorineural hearing loss

351

2053

1.14

1.59

1.1

290.80

432.42

mg/l

0.50

319

1869

Other disorders of breast

472

1.36

1.59

1.1

302.45

299.44

mg/l

0.13

421

Pregnancy with abortive outcome

296

1335

1.16

1.57

1.1

300.97

301.76

mg/l

0.06

264

1204

Embolic stroke

1.82

1.57

1.0

1.1

322.22

290.54

mg/l

1.18

Gonarthrosis, primary, with knee surgery

187

1726

0.84

1.55

1.1

281.58

462.19

mg/l

0.54

160

1568

COPD, hospital admissions 3, with asthma pneumonia sepsis

621

1.28

1.55

1.0

1.1

312.19

282.96

mg/l

3.04

566

Kyphosis

2.45

1.54

1.0

1.1

291.25

282.07

mg/l

—

Endometriosis of pelvic peritoneum

503

1.32

1.51

1.1

307.09

889.42

mg/l

0.50

456

Dementia in Alzheimer disease

300

0.61

1.50

1.0

280.87

294.84

mg/l

0.31

264

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

769

0.74

1.50

1.1

1.0

304.90

287.88

mg/l

0.90

701

Acquired haemolytic anaemia

2.08

1.49

1.1

317.33

289.36

mg/l

0.44

Ischaemic Stroke, excluding all haemorrhages

229

1444

1.17

1.49

1.1

287.61

290.95

mg/l

0.30

204

1306

Open wound of wrist and hand

234

1947

1.16

1.48

1.1

286.74

281.54

mg/l

0.49

212

1805

Other/unspecified seropositive rheumatoid arthritis

108

866

1.25

1.47

1.0

1.1

293.39

293.82

mg/l

0.02

783

LSIL lesion of the vagina

2.24

1.47

1.0

313.60

295.12

mg/l

—

Crystal arthropathies, rheuma endpoint

2.24

1.47

1.0

1.1

275.90

301.79

mg/l

—

Salpingitis and oophoritis

601

1.30

1.46

1.0

1.1

301.42

298.66

mg/l

0.13

535

Contact with and exposure to communicable diseases

111

1365

0.81

1.46

1.1

285.46

288.38

mg/l

0.14

1272

Burns and corrosions

549

1.31

1.46

1.0

1.1

285.31

283.35

mg/l

0.08

506

Benign neoplasm of mouth and pharynx

360

1.39

1.46

1.0

1.1

296.18

288.72

mg/l

0.28

330

Polyarthritis, unspecified

117

1.72

1.45

1.2

1.1

271.25

295.61

mg/l

0.75

105

Need for immunization against other single viral diseases

1.99

1.44

1.2

1.0

309.23

278.10

mg/l

0.63

Impacted cerumen

353

1.39

1.43

1.0

282.56

289.75

mg/l

0.22

315

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

106

852

1.25

1.42

1.0

1.1

292.46

293.93

mg/l

0.07

772

Status epilepticus

103

1.76

1.41

1.1

281.39

282.49

mg/l

0.02

Dislocation, sprain and strain of joints and ligaments of knee

320

2556

1.13

1.40

1.1

279.85

401.23

mg/l

0.55

290

2355

Effects of foreign body entering through natural orifice

122

998

1.22

1.40

1.0

1.1

272.02

280.27

mg/l

0.56

115

918

Other bursopathies

397

1.36

1.40

1.0

1.1

307.35

286.62

mg/l

1.39

360

Conductive and sensorineural hearing loss

374

2210

1.12

1.39

1.1

288.92

422.55

mg/l

0.51

340

2012

Type of accident

139

1154

1.21

1.38

1.1

288.52

286.27

mg/l

0.12

128

1056

Unknown and unspecified causes of morbidity

198

1.52

1.37

1.0

1.1

297.50

287.09

mg/l

0.31

176

Isolated growth hormone deficiency

2.98

1.36

1.0

1.2

360.80

268.18

mg/l

—

Seropositive rheumatoid arthritis, wide

108

875

1.24

1.36

1.0

1.1

293.39

293.52

mg/l

0.01

792

Lateral epicondylitis

486

1.32

1.35

1.0

1.1

5119.35

288.26

mg/l

0.49

442

Chalazion

417

1.35

1.1

299.29

290.42

mg/l

0.41

384

Dentofacial anomalies [including malocclusion]

379

2652

1.12

1.34

1.0

1.1

287.36

399.54

mg/l

0.52

340

2441

Other crystal arthropathies

2.14

1.34

1.0

1.1

275.90

296.29

mg/l

—

Benign thyroid growths and nodules

135

1043

1.20

1.32

1.1

296.27

298.85

mg/l

0.18

126

935

Bronchitis, not specified as acute or chronic

283

1.42

1.31

1.1

281.83

284.18

mg/l

0.09

262

Excessive attrition of teeth

315

2769

1.13

1.30

1.1

289.81

289.29

mg/l

0.04

282

2554

Eustachian salpingitis and obstruction

326

1.39

1.30

1.0

1.1

284.85

277.24

mg/l

0.32

302

Strabismus

126

1042

1.21

1.28

1.0

1.1

288.68

287.62

mg/l

0.06

116

952

Postpartum haemorrhage due to anatomy

335

1.38

1.28

1.1

294.10

296.26

mg/l

0.08

317

Use of glatiramer acetate

1.95

1.28

1.2

1.1

260.75

288.49

mg/l

0.77

Organic, including symptomatic, mental disorders

192

1158

1.17

1.27

1.1

1.0

296.28

291.59

mg/l

0.37

172

1038

142

1072

1.19

1.26

1.0

300.48

292.83

mg/l

0.63

124

957

Carcinoma in situ of skin of lower limb, including hip

2.23

1.24

1.3

1.1

300.00

288.68

mg/l

—

Conjunctivitis (acute, non atopic)

139

1163

1.19

1.24

1.1

291.64

288.82

mg/l

0.12

129

1069

Other and unspecified mononeuropathies, also in other diseases

1.87

1.24

1.2

1.1

309.38

288.05

mg/l

0.42

Benign leiomyoma with endometriosis

476

1.31

1.24

1.1

1.0

296.13

300.39

mg/l

0.20

424

Hydrocele

372

1.35

1.23

1.1

279.60

272.58

mg/l

0.30

345

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

281

1930

1.13

1.23

1.1

295.91

449.28

mg/l

0.51

259

1757

Uterine polyps

115

551

1.22

1.23

1.0

1.1

299.28

842.03

mg/l

0.51

107

495

Appendectomy

327

2782

1.12

1.23

1.0

1.1

293.81

392.48

mg/l

0.46

295

2553

Other disorders of the musculoskeletal system and connective tissue

495

1.30

1.21

1.1

298.88

290.47

mg/l

0.36

453

Unspecified acute lower respiratory infection

557

1.28

1.21

1.1

293.24

279.68

mg/l

0.80

513

Coronary artery bypass grafting

483

1.26

1.21

1.0

1.1

303.68

283.23

mg/l

1.38

426

Injuries to the elbow and forearm

359

2766

1.11

1.21

1.0

1.1

296.77

393.10

mg/l

0.44

330

2533

Pathological resorption of teeth

124

1.62

1.21

1.1

256.55

284.17

mg/l

1.57

112

Excessive earwax

296

2386

1.12

1.21

1.1

287.92

288.29

mg/l

0.03

271

2167

Any dementia

708

0.80

1.20

1.0

289.97

292.35

mg/l

0.11

632

Complications of the puerperium, not elsewhere classified

132

1.60

1.20

1.1

1.0

295.29

305.47

mg/l

0.33

124

Other peripheral vascular diseases

263

1.41

1.20

1.1

1.0

304.00

292.61

mg/l

0.36

243

Bullous disorders

164

1.53

1.20

1.0

291.40

287.50

mg/l

0.09

147

Speech therapy

110

908

1.21

1.20

1.1

302.18

289.00

mg/l

1.24

825

Tobacco use

197

1.48

1.19

1.1

277.59

284.33

mg/l

0.18

182

Dermatographic urticaria

239

1.43

1.18

1.1

275.91

296.68

mg/l

1.03

217

Focal epilepsy, strict definition

666

1.25

1.18

1.1

282.80

285.21

mg/l

0.09

607

Pulmonary embolism

113

937

1.21

1.17

1.1

1.0

316.12

286.79

mg/l

3.46

105

848

Alopecia areata

1.78

1.17

1.1

302.64

294.96

mg/l

0.15

Amiodarone users

290

1.38

1.17

1.0

310.90

284.90

mg/l

1.34

262

Raynaud syndrome

333

1.36

1.16

1.0

295.31

291.90

mg/l

0.09

304

Disorders of ocular muscles, binocular movement, accommodation and refraction

240

2097

1.14

1.16

1.0

1.1

283.38

289.95

mg/l

0.71

220

1921

Other strabismus

105

863

1.21

1.16

1.0

1.1

291.90

288.31

mg/l

0.21

793

Pulmonary heart disease

113

939

1.20

1.15

1.1

1.0

316.12

287.04

mg/l

3.41

105

849

Multiple myeloma, including Hilmo

110

1.64

1.15

1.1

1.0

314.22

296.47

mg/l

0.38

Other otitis externa (chronic)

232

1.43

1.15

1.1

1.0

313.85

293.25

mg/l

0.89

213

Secondary uncertain malignant neoplasm

377

1.33

1.15

1.1

1.0

313.93

285.26

mg/l

1.85

343

Alzheimer’s disease (Late onset), excluding more controls

186

0.63

1.14

1.0

289.00

303.23

mg/l

0.38

165

Lesion of ulnar nerve

501

1.28

1.13

1.1

289.15

284.92

mg/l

0.19

459

Sudden idiopathic hearing loss

318

1.36

1.12

1.0

1.1

314.70

292.17

mg/l

0.94

290

Varicose veins

245

1634

1.13

1.12

1.0

1.1

302.26

473.90

mg/l

0.47

223

1487

Delivery

122

767

0.84

1.12

1.0

1.1

295.44

310.86

mg/l

1.91

106

683

In situ neoplasms

158

1357

1.17

1.12

1.1

298.16

295.37

mg/l

0.18

144

1230

Other and unspecified types of non-Hodgkin lymphoma, hilmo

115

0.43

1.12

1.0

323.80

285.39

mg/l

—

102

Single delivery by caesarean section

436

1.23

1.11

1.1

300.99

315.69

mg/l

0.91

398

Panhypopituitarism

1.98

1.11

1.0

1.1

335.70

282.00

mg/l

—

Peritonsillar abscess

807

1.22

1.11

1.1

290.39

283.96

mg/l

0.34

756

Sequelae of external causes of morbidity and mortality

108

898

1.20

1.11

1.0

1.1

299.99

288.29

mg/l

0.85

101

816

Benign neoplasm: Pituitary gland, craniopharyngeal duct

184

1.47

1.11

1.1

309.56

287.05

mg/l

0.80

167

Pedestrian injured in transport accident

251

1.40

1.10

1.1

287.90

mg/l

0.00

230

Hypoglycaemia, other or unspecified

226

1.42

1.09

1.1

308.75

286.08

mg/l

0.76

206

Other abortion

2.40

1.09

1.0

278.40

281.38

mg/l

—

Gestational [pregnancy-induced] hypertension

114

953

1.20

1.09

1.1

282.12

302.65

mg/l

2.33

109

854

Congenital malformations of the circulatory system

541

1.26

1.08

1.1

305.38

286.52

mg/l

0.90

500

Other disorders of central nervous system

2.20

1.08

1.0

274.14

285.07

mg/l

—

Delivery, wide proxy

607

0.82

1.08

1.0

1.1

301.14

312.22

mg/l

0.77

541

Sequelae with surgical and medical care as external cause

675

1.23

1.07

1.0

306.01

289.08

mg/l

1.14

614

Multiple delivery

303

0.66

1.07

1.1

285.15

312.35

mg/l

1.17

266

Papillary adenocarcinoma of thyroid gland

180

0.55

1.06

1.1

1.0

288.40

292.66

mg/l

—

162

Postpartum hemorraghe, parous women as controls

113

792

1.19

1.06

1.0

1.1

298.78

296.50

mg/l

0.11

102

735

Chronic myeloproliferative disease

2.14

1.06

1.0

1.1

302.00

283.36

mg/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

150

1291

1.16

1.05

1.1

288.02

284.46

mg/l

0.22

130

1193

Other bullous disorders

1.72

1.05

1.0

273.21

287.70

mg/l

0.25

Procedures for purposes other than remedying health state

1.80

1.05

1.2

1.1

294.50

294.36

mg/l

0.00

Abnormal findings in secretions and smears from cervix uteri vagina vulva

234

1526

1.13

1.04

1.0

1.1

300.72

494.53

mg/l

0.51

217

1386

Nasal polyp

633

1.23

1.04

1.0

1.1

293.51

281.87

mg/l

0.81

583

Inguinal hernia

221

1657

0.89

1.02

1.1

275.38

278.79

mg/l

0.32

204

1528

Carrier of infectious disease

1.77

1.00

1.0

1.1

293.92

290.97

mg/l

0.03

Foreign body entering into or through eye or natural orifice

299

1.34

1.00

1.1

266.74

278.35

mg/l

0.36

274

Hypogonadotropic hypogonadism

139

1.52

1.00

1.0

1.1

272.90

272.64

mg/l

0.00

130

Operations for atrial fibrillation

1.85

0.99

1.0

323.67

289.61

mg/l

—

Female infertility

119

603

1.18

0.98

1.0

1.1

293.21

791.19

mg/l

0.51

107

546

Actinic keratosis

122

946

1.17

0.97

1.0

300.39

294.50

mg/l

0.39

108

838

Other disorders of ear

451

2682

1.09

0.96

1.0

1.1

289.88

398.13

mg/l

0.50

411

2456

Trochanteric bursitis

469

1.26

0.96

1.1

300.38

295.25

mg/l

0.27

422

Acquired stenosis of external ear canal

0.00

0.95

0.0

1.0

—

282.27

—

Infectious mononucleosis

328

1.31

0.95

1.1

311.82

288.08

mg/l

0.68

305

Infectious mononucleosis, including avohilmo

328

1.31

0.95

1.1

311.82

288.08

mg/l

0.68

305

Ganglion

777

1.20

0.95

1.1

296.44

292.16

mg/l

0.21

712

Habit and impulse disorders

1.79

0.94

1.0

1.1

349.27

264.30

mg/l

0.87

Allergic purpura

1.65

0.94

1.1

299.71

291.73

mg/l

0.13

Hypertensive Renal Disease

1.78

0.94

1.0

1.1

315.09

278.13

mg/l

2.08

Exposure to other and unspecified animate mechanical forces

101

1.59

0.93

1.0

1.1

265.50

289.92

mg/l

0.97

Degenerative diseases of the nervous system

649

0.82

0.93

1.0

280.68

291.58

mg/l

0.70

581

Postmenopausal atrophic vaginitis

103

471

1.19

0.92

1.1

304.72

937.66

mg/l

0.50

421

Disorders in reading

1.74

0.92

1.0

1.1

276.22

283.50

mg/l

—

Hyperkinetic disorders (excl. ADHD)

1.72

0.92

1.0

1.1

305.08

285.28

mg/l

0.34

Other disorders of bladder

339

1.30

0.92

1.1

1.0

279.66

287.55

mg/l

0.37

311

Benign neoplasm of ovary

526

1.24

0.91

1.0

1.1

306.57

299.92

mg/l

0.24

467

Nontraumatic intracranial haemmorrhage

526

1.24

0.91

1.0

1.1

287.53

287.89

mg/l

0.01

478

Dermatophytosis, including avohilmo

326

2914

1.10

0.91

1.1

286.02

287.95

mg/l

0.20

299

2663

Other disorders of Eustachian tube

1.60

0.90

1.2

1.1

279.53

290.46

mg/l

0.32

Contact with machinery

393

1.28

0.90

1.1

272.31

277.82

mg/l

0.29

364

Diabetic retinopathy

196

1077

1.13

0.90

1.0

1.1

300.42

285.42

mg/l

1.90

176

969

Premature rupture of membranes

101

607

1.19

0.89

1.1

293.78

306.28

mg/l

0.96

556

Meniscus derangement

253

1512

1.11

0.88

1.1

284.13

481.52

mg/l

0.52

231

1382

Glaucoma

182

1740

0.89

0.87

1.0

1.1

293.40

292.69

mg/l

0.05

168

1565

Retinal breaks without detachment

548

1.22

0.87

1.1

286.27

289.73

mg/l

0.17

493

Acute bronchiolitis

183

1.38

0.86

1.1

293.89

287.25

mg/l

0.19

167

Artrosis, including avohilmo

411

2074

1.09

0.86

1.0

1.1

279.49

289.90

mg/l

1.96

372

1910

Male infertility

204

0.63

0.86

1.0

1.1

272.31

265.17

mg/l

0.17

191

Erythema intertrigo

1.67

0.85

1.0

348.50

279.10

mg/l

0.49

Certain conditions originating in the perinatal period

281

1.30

0.84

1.0

1.1

291.69

294.16

mg/l

0.06

262

Sixth [abducent] nerve palsy

1.60

0.84

1.0

280.00

289.91

mg/l

0.17

Iridocyclitis

844

1.17

0.83

1.1

293.31

285.82

mg/l

0.50

771

Polyp of the female genital tract

117

570

1.16

0.82

1.0

1.1

298.80

823.00

mg/l

0.51

107

513

Spondylopathies in diseases classified elsewhere

1.89

0.82

1.2

1.1

279.17

266.85

mg/l

—

Oral leukoplakia, including avohilmo

1.58

0.81

1.0

1.1

294.44

284.92

mg/l

—

Polycythaemia vera

1.58

0.81

1.1

1.0

301.29

282.68

mg/l

0.52

Allergic colitis

1.71

0.80

1.0

1.1

246.75

284.62

mg/l

—

Postpartum hemorraghe, all women as controls

113

953

1.16

0.80

1.0

1.1

298.78

302.27

mg/l

0.18

102

876

Zoster [herpes zoster], including avohilmo

224

1952

1.11

0.80

1.1

299.48

291.39

mg/l

0.89

212

1763

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

626

1.19

0.79

1.1

302.15

285.26

mg/l

0.85

578

Inflammatory disease of uterus

473

1.23

0.79

1.0

1.1

306.27

301.28

mg/l

0.19

430

Skin changes due to chronic exposure to nonionizing radiation

125

987

1.15

0.78

1.0

300.75

294.05

mg/l

0.47

110

876

Primary gonarthrosis, bilateral

177

1657

0.89

0.78

1.1

288.52

469.06

mg/l

0.51

148

1504

Short Achilles tendon (acquired)

1.59

0.78

1.1

291.38

291.82

mg/l

0.01

Other fall from one level to another

103

887

1.16

0.78

1.0

1.1

289.16

284.63

mg/l

0.27

815

Leisure time condition

657

1.19

0.77

1.1

276.72

286.56

mg/l

0.65

604

Female infertility, cervical, vaginal, other or unspecified origin

108

595

1.16

0.77

1.0

1.1

292.78

797.75

mg/l

0.51

539

Other epidermal thickening

140

1.43

0.77

1.1

285.90

284.43

mg/l

0.03

126

Primary open-angle glaucoma

845

0.84

0.76

1.0

289.15

291.29

mg/l

0.10

755

Allergic contact dermatitis due to drugs in contact with skin

1.71

0.75

1.1

300.33

295.52

mg/l

—

Puerperal sepsis

413

1.24

0.75

1.0

1.1

285.15

301.43

mg/l

1.11

365

malignant neoplasm of female genital organs

450

0.78

0.75

1.1

1.0

302.39

299.60

mg/l

0.10

403

Long labour

798

0.85

0.75

1.0

1.1

302.70

303.73

mg/l

0.04

727

Other disorders of cornea

333

1.26

0.74

1.0

289.65

288.22

mg/l

0.05

305

Single spontaneous delivery

127

765

0.88

0.74

1.0

1.1

298.70

311.03

mg/l

1.29

111

681

Mixed conductive and sensorineural hearing loss

360

1.25

0.74

1.0

285.87

291.07

mg/l

0.19

330

Malignant neoplasm of breast, ER-positive, including Hilmo

111

947

0.87

0.74

1.1

1.0

313.48

609.22

mg/l

0.47

856

Corneal ulcer

716

1.17

0.74

1.1

1.0

297.47

285.35

mg/l

0.72

659

HSIL lesion of the vagina

1.85

0.73

1.0

1.1

309.57

297.36

mg/l

—

Brachial plexus disorders

334

1.26

0.73

1.1

6628.60

289.79

mg/l

0.49

307

Acute appendicitis

343

2947

1.08

0.72

1.1

288.36

386.04

mg/l

0.49

313

2707

Haemorrhagic and haematological disorders of fetus and newborn

1.60

0.72

1.0

1.1

301.89

278.15

mg/l

—

Superficial injury of forearm

389

1.24

0.71

1.0

1.1

281.16

288.35

mg/l

0.25

355

Infection due to other mycobacteria

1.93

0.70

1.2

1.1

324.80

261.79

mg/l

—

Malignant neoplasm of breast, HER-positive

111

944

0.87

0.70

1.1

1.0

313.48

610.45

mg/l

0.47

853

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

327

1.26

0.70

1.0

331.86

288.77

mg/l

1.02

297

Chronic suppurative otitis media, including avohilmo

256

1.29

0.70

1.0

1.1

296.55

292.17

mg/l

0.09

234

Covid-19 suspected case

102

888

1.15

0.70

1.1

299.62

288.42

mg/l

0.77

823

Seborrhoeic keratosis

832

1.16

0.69

1.1

286.13

289.33

mg/l

0.18

758

Outcome of delivery

389

1.18

0.69

1.0

1.1

309.76

312.08

mg/l

0.10

360

Hypoplasia of dental enamel

1.85

0.68

1.4

1.0

261.40

304.07

mg/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

674

1.17

0.68

1.1

302.32

285.25

mg/l

0.92

624

Herpesviral [herpes simplex] infections, including avohilmo

117

1032

1.13

0.67

1.0

1.1

298.64

292.57

mg/l

0.27

110

938

Benign neoplasm: Skin of trunk

136

1.40

0.67

1.0

1.1

325.32

289.79

mg/l

0.37

124

Acute laryngitis and tracheitis

513

1.19

0.66

1.1

278.14

279.99

mg/l

0.07

477

Focal epilepsy

743

1.16

0.66

1.1

283.81

285.61

mg/l

0.07

679

Myasthenia gravis

1.60

0.65

1.0

305.29

286.36

mg/l

—

Ectopic pregnancy

633

1.17

0.65

1.0

1.1

320.61

298.42

mg/l

1.32

569

Embedded and impacted teeth

136

985

1.12

0.64

1.1

285.38

283.98

mg/l

0.06

129

915

Viral conjunctivitis, including avohilmo

129

1.40

0.63

1.1

1.0

299.33

292.44

mg/l

0.16

118

Benign neoplasm: Skin of other and unspecified parts of face

314

1.24

0.63

1.1

1.0

270.68

290.18

mg/l

1.80

283

Gestational diabetes (for exclusion)

166

1030

1.11

0.63

1.0

1.1

300.32

300.87

mg/l

0.04

152

950

Melanocytic naevi

140

1256

1.12

0.62

1.1

288.85

290.45

mg/l

0.09

130

1145

Viral conjunctivitis

1.56

0.62

1.1

295.18

287.11

mg/l

0.13

Non-small cell lung cancer, squamous, helper endpoint

101

0.59

0.62

1.0

381.33

290.94

mg/l

—

Dysplasia of cervi uteri

571

1.15

0.61

1.1

306.10

817.96

mg/l

0.50

518

Intracerebral haemorrhage

316

1.24

0.60

1.0

300.85

287.61

mg/l

0.54

286

Gonarthrosis

282

1476

1.08

0.59

1.0

1.1

280.78

487.86

mg/l

0.53

246

1348

Disorders of puberty, all

1.54

0.59

1.0

1.1

284.00

297.33

mg/l

—

Hypertrophy of breast

667

1.16

0.59

1.2

1.0

289.04

302.30

mg/l

1.17

599

Benign neoplasm: Skin of eyelid, including canthus

491

1.18

0.59

1.0

295.36

292.08

mg/l

0.12

443

Hypertrophy of breast in women and men

789

1.14

0.59

1.2

1.0

287.89

298.73

mg/l

1.00

714

Colorectal adenocarcinoma

567

1.17

0.58

1.0

291.71

285.70

mg/l

0.34

512

Other osteochondropathies

255

1.26

0.58

1.1

261.33

285.17

mg/l

1.54

237

Foreign body in ear

1.49

0.57

1.0

1.1

273.25

297.47

mg/l

—

Embolic stroke with flimmer

1.67

0.56

1.0

309.83

295.33

mg/l

—

0.57

0.56

1.0

1.1

269.80

284.84

mg/l

—

Carcinoma in situ of skin of scalp and neck

1.46

0.56

1.0

329.25

295.96

mg/l

—

Endometriosis ASRM stages 1,2

643

1.15

0.56

1.1

308.45

298.80

mg/l

0.55

578

Hereditary retinal dystrophy

1.63

0.55

1.0

1.1

317.67

287.84

mg/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.63

0.55

1.2

1.1

270.33

287.39

mg/l

—

Granuloma annulare

1.63

0.55

3.0

1.0

281.00

297.69

mg/l

—

Suggestive for eosinophilic asthma

311

1.22

0.55

1.1

290.66

287.94

mg/l

0.08

286

Nail disorders

284

1.23

0.55

1.0

1.1

276.37

287.05

mg/l

0.47

258

Retinal detachment with retinal break

394

1.19

0.54

1.0

1.1

283.31

285.81

mg/l

0.09

357

Assault by unspecified means

1.47

0.54

1.2

1.1

296.00

276.18

mg/l

0.33

Injury of muscle and tendon at lower leg level

570

1.16

0.54

1.1

281.67

283.53

mg/l

0.07

522

Acute alcohol intoxication ICD-9

1.47

0.54

1.0

319.25

292.33

mg/l

0.75

Pedestrian injured in collision with pedal cycle

1.42

0.54

1.2

1.1

284.21

283.07

mg/l

0.01

Multiple gestation

328

0.79

0.54

1.0

1.1

288.92

302.17

mg/l

0.58

301

malignant neoplasm of female genital organs, including Hilmo

510

0.84

0.53

1.1

1.0

308.46

298.60

mg/l

0.51

458

Other benign neoplasms of connective and other soft tissue

340

1.21

0.53

1.0

304.76

291.42

mg/l

0.40

311

Medicines for HER+ breast cancer

122

1259

0.90

0.53

1.1

1.0

311.58

537.06

mg/l

0.47

109

1127

Presbycusis

268

0.77

0.52

1.0

296.69

297.51

mg/l

0.02

240

Malignant neoplasm of testis

1.43

0.52

1.2

1.1

241.22

260.26

mg/l

—

1.52

0.52

1.0

1.1

266.50

283.33

mg/l

—

Non-small cell lung cancer, squamous

0.62

0.52

1.0

381.33

283.11

mg/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

266

2378

1.07

0.52

1.1

293.23

414.33

mg/l

0.49

241

2180

Macular pucker

424

1.18

0.52

1.1

1.0

316.69

291.85

mg/l

1.42

377

Coxarthrosis, primary, with hip surgery

145

1474

0.91

0.51

1.1

289.97

292.49

mg/l

0.17

128

1324

Aortic aneurysm

617

1.14

0.51

1.1

294.18

281.11

mg/l

0.79

567

Acute nasopharyngitis (common cold)

495

1.16

0.51

1.1

285.65

275.91

mg/l

0.59

459

Postpartum haemorrhage

113

838

1.11

0.51

1.0

1.1

298.78

303.17

mg/l

0.23

102

768

Vascular dementia

147

1.31

0.51

1.1

1.0

308.07

290.41

mg/l

0.35

131

Other specific arthropathies, wide

1.39

0.50

1.0

1.1

319.11

293.68

mg/l

—

Dementia

109

829

0.90

0.50

1.0

299.53

294.16

mg/l

0.32

739

Ankylosing hyperostosis [Forestier]

1.47

0.50

1.0

1.1

323.33

265.25

mg/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

640

1.14

0.50

1.1

286.62

284.73

mg/l

0.07

584

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

134

1220

1.10

0.49

1.1

284.14

280.66

mg/l

0.22

119

1118

Toxic effects of substances chiefly nonmedicinal as to source

427

1.17

0.49

1.1

287.11

286.42

mg/l

0.02

399

Other disorders involving the immune mechanism, not elsewhere classified

110

1.37

0.49

1.1

253.87

276.91

mg/l

0.54

100

Dislocation, sprain and strain of joints and ligaments of thorax

109

0.64

0.48

1.1

244.57

286.08

mg/l

—

Presence of other functional implants

235

1499

1.07

0.48

1.1

293.21

487.82

mg/l

0.49

209

1343

Other hearing loss

788

1.12

0.47

1.0

299.52

292.93

mg/l

0.35

712

Obstructed labour due to malposition and malpresentation of fetus

833

0.89

0.47

1.1

290.63

304.51

mg/l

1.25

767

Unspecified nephritic syndrome

1.48

0.47

1.1

267.80

276.93

mg/l

—

Coxarthrosis

210

1259

1.08

0.46

1.1

288.55

523.23

mg/l

0.50

191

1141

Unspecified lump in breast

516

0.85

0.46

1.2

1.0

300.86

297.23

mg/l

0.17

461

Acute appendicitis, no complications

267

2492

1.07

0.46

1.1

291.09

286.95

mg/l

0.44

247

2288

Stenosis and insufficiency of lacrimal passages

291

1.20

0.46

1.1

1.0

288.43

296.10

mg/l

0.31

266

Medial epicondylitis

120

1.34

0.46

1.0

1.1

292.69

285.24

mg/l

0.16

107

Scissor bite

1.39

0.46

1.2

1.1

263.23

286.93

mg/l

0.74

Coxarthrosis [arthrosis of hip](FG)

228

1464

1.07

0.45

1.1

290.00

489.87

mg/l

0.50

205

1331

Gonarthrosis,primary

368

2339

0.95

0.45

1.1

288.83

415.39

mg/l

0.51

324

2141

Pedal cyclist injured in transport accident

102

922

1.11

0.45

1.1

282.57

285.50

mg/l

0.17

850

Twin gestation

319

0.81

0.44

1.0

1.1

288.92

302.42

mg/l

0.60

292

Benign neoplasm: Tongue

1.40

0.44

1.2

1.0

288.67

294.24

mg/l

0.10

Oesophageal obstruction

1.40

0.44

1.1

1.0

277.50

295.68

mg/l

0.47

Left ventricular outflow tract obstruction (LVOTO), broad definition

404

1.17

0.44

1.1

321.95

280.05

mg/l

2.28

376

Acne, including avohilmo

774

0.90

0.43

1.2

1.1

299.80

285.74

mg/l

0.63

725

Other and unspecified mononeuropathies of upper limb

0.66

0.42

1.0

1.1

278.67

284.31

mg/l

—

L02BG Aromatase inhibitors

1036

0.90

0.42

1.1

1.0

301.17

591.98

mg/l

0.50

919

Peripheral retinal degeneration

0.65

0.42

1.0

1.1

288.33

282.75

mg/l

—

Any dementia, excluding more controls

599

0.89

0.42

1.0

290.22

298.90

mg/l

0.48

535

Benign neoplasm: Larynx

0.63

0.42

1.2

1.1

287.50

279.17

mg/l

—

Fracture at wrist and hand level

165

1526

1.08

0.42

1.1

288.49

280.66

mg/l

0.79

152

1410

Other surgical follow-up care

1.36

0.41

1.2

1.1

283.00

277.57

mg/l

0.12

Benign neoplasm: Vagina

1.52

0.41

1.0

1.1

288.00

300.25

mg/l

—

Lichen simplex chronicus

105

1.34

0.41

1.0

1.1

286.14

282.71

mg/l

0.08

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.41

0.0

1.1

—

303.47

—

Malignant neoplasm of breast

157

1092

0.93

0.40

1.1

310.91

567.49

mg/l

0.47

137

993

Mental and behavioural disorders due to use of other stimulants, including caffeine

123

1.30

0.40

1.0

1.1

284.94

273.12

mg/l

0.40

112

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.34

0.40

1.0

1.1

263.63

271.44

mg/l

—

LSIL lesion of the cervix uteri, vagina or vulva

530

1.13

0.40

1.1

301.40

298.04

mg/l

0.16

482

Dislocation, sprain and strain of joints and ligaments of head

150

1.27

0.40

1.2

1.1

259.26

289.15

mg/l

2.09

136

Dementia, including avohilmo

124

920

0.92

0.40

1.0

296.12

293.62

mg/l

0.14

107

822

Malignant neoplasm of breast, HER2-negative

157

1091

0.93

0.40

1.1

310.91

567.75

mg/l

0.47

137

992

Ménière disease

278

1.19

0.40

1.2

1.0

283.24

292.09

mg/l

0.37

253

Urethritis and urethral syndrome

1.31

0.39

1.3

1.1

268.00

297.00

mg/l

—

Pedestrian injured in collision with car, pick-up truck or van

1.41

0.39

1.1

257.00

282.82

mg/l

—

Malignant neoplasm of breast, including Hilmo

161

1109

0.93

0.39

1.1

311.52

563.21

mg/l

0.47

141

1009

Malignant neoplasm of breast, HER2-negative, including Hilmo

161

1109

0.93

0.39

1.1

311.52

563.21

mg/l

0.47

141

1009

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

106

1.32

0.39

1.1

256.29

274.93

mg/l

0.38

Carcinoma in situ of breast, intraductal

248

0.81

0.39

1.1

1.0

315.08

298.33

mg/l

0.48

217

Supervision of high-risk pregnancy

472

1.11

0.38

1.1

297.06

309.48

mg/l

0.95

440

Separation of retinal layers (serosa)

151

1.26

0.38

1.2

1.1

268.79

275.41

mg/l

0.18

138

Other aneurysm

160

1.25

0.38

1.1

312.30

282.23

mg/l

1.01

149

Other and unspecified intracranial injuries

1.35

0.38

1.2

1.0

305.42

290.50

mg/l

0.37

Other and unspecified visual disturbances

373

1.15

0.37

1.0

1.1

283.76

293.26

mg/l

0.34

342

Aggressive periodontitis

1.33

0.37

1.0

287.22

281.79

mg/l

—

Other and unspecified corneal deformities and disorders

1.33

0.37

1.1

298.38

284.07

mg/l

0.44

Other disorders of conjunctiva

458

1.14

0.37

1.0

287.50

291.41

mg/l

0.12

414

Malignant neoplasm of testis, including Hilmo

1.27

0.36

1.2

1.1

241.22

265.97

mg/l

—

Other and unspecified disease of Bartholin gland

0.65

0.35

1.0

268.60

302.55

mg/l

—

Allergic conjunctivitis

276

2523

1.05

0.35

1.1

292.47

407.40

mg/l

0.50

251

2313

Atrial septal defect

123

0.73

0.35

1.0

1.1

337.33

287.83

mg/l

—

113

Other menopausal disorders

532

0.91

0.34

1.0

1.1

299.52

862.14

mg/l

0.51

478

Chronic iridocyclitis

163

1.23

0.34

1.2

1.0

277.15

288.29

mg/l

0.46

147

Disorders of puberty

1.31

0.33

1.0

1.1

257.00

295.73

mg/l

—

Injury of muscle and tendon at shoulder and upper arm level

144

1348

1.07

0.32

1.1

289.05

282.07

mg/l

0.53

125

1245

Lymphoid leukaemia

155

1.23

0.32

1.0

299.36

286.00

mg/l

0.28

140

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.33

0.32

1.1

1.0

264.55

306.83

mg/l

1.23

Glaucoma secondary to other eye disorders

119

1.26

0.31

1.0

1.1

305.00

287.12

mg/l

0.51

108

Pregnancy, childbirth and the puerperium

479

0.91

0.31

1.0

1.1

293.72

313.31

mg/l

1.41

426

Fracture of femur

651

1.09

0.31

1.1

305.10

288.48

mg/l

1.17

585

Carcinoma in situ, bladder

0.71

0.31

1.0

285.43

283.02

mg/l

—

Preterm labour and delivery

106

984

1.08

0.30

1.1

301.97

303.91

mg/l

0.11

882

All dysplastic lesions of the cervix uteri, vagina or vulva

123

1120

1.07

0.30

1.1

307.00

300.72

mg/l

0.47

114

1016

Congenital malformations of heart and great arteries

480

1.11

0.30

1.1

303.62

286.38

mg/l

0.59

444

Carcinoma in situ of cervix uteri

357

0.87

0.30

1.1

1.0

315.77

301.58

mg/l

0.54

326

Other abnormal products of conception

144

886

1.07

0.30

1.1

304.21

299.88

mg/l

0.26

132

814

Cystic kidney disease, including avohilmo

111

1.26

0.30

1.1

291.14

276.47

mg/l

0.25

101

Neovascular glaucoma

111

1.26

0.30

1.0

1.1

308.29

284.42

mg/l

0.70

100

Nontoxic goitre/thyroid nodule

107

995

1.08

0.30

1.1

1.0

292.39

298.63

mg/l

0.47

887

Diabetic maculopathy

549

1.10

0.29

1.1

298.93

282.74

mg/l

0.97

493

Labour and delivery complicated by umbilical cord complications

157

1.21

0.29

1.1

1.0

286.47

300.21

mg/l

0.35

144

Venous complications and haemorrhoids in pregnancy

1.25

0.29

1.0

281.14

299.57

mg/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

175

1122

1.06

0.29

1.1

1.0

302.81

287.18

mg/l

2.10

155

1018

Carcinoma in situ of other and unspecified sites

107

0.75

0.29

1.0

292.25

283.25

mg/l

—

Injuries to the hip and thigh

187

1590

1.05

0.28

1.1

295.43

287.95

mg/l

0.59

170

1441

Colorectal cancer, including Hilmo

767

1.08

0.28

1.1

1.0

298.55

287.52

mg/l

0.72

697

Cystic kidney disease

103

1.26

0.28

1.2

1.1

292.77

275.04

mg/l

0.29

Malignant neoplasm of prostate, including Hilmo

524

0.92

0.27

1.0

1.1

269.59

273.14

mg/l

0.19

485

Transient ischemic attack

172

1442

0.95

0.26

1.0

1.1

284.38

292.55

mg/l

0.86

156

1295

Disorders of synovium and tendon in diseases classified elsewhere

0.70

0.26

1.0

1.1

305.60

278.56

mg/l

—

Malignant neoplasm of bladder, including Hilmo

259

1.14

0.26

1.1

1.0

279.00

282.62

mg/l

0.11

231

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

184

1181

1.05

0.25

1.1

1.0

302.64

536.36

mg/l

0.46

165

1070

Ulcer of vagina/vulva

1.23

0.25

1.0

285.33

309.59

mg/l

—

Bursitis of shoulder

1.20

0.25

1.0

1.1

333.89

278.62

mg/l

—

malignant neoplasm of male genital organs, including Hilmo

580

0.93

0.25

1.1

268.57

272.11

mg/l

0.20

537

Monoarthritis, not elsewhere classified

142

1.20

0.24

1.0

1.1

299.71

293.18

mg/l

0.16

131

Flat foot [pes planus] (acquired)

340

1.12

0.24

1.1

292.93

297.41

mg/l

0.13

305

Malignant neoplasm of prostate

516

0.93

0.24

1.0

1.1

269.12

273.00

mg/l

0.21

478

Ectropion of eyelid

0.74

0.24

1.0

282.83

297.10

mg/l

—

Myeloid leukaemia

0.72

0.24

1.2

1.0

326.17

279.76

mg/l

—

Later onset COPD

512

1.08

0.23

1.1

1.0

294.85

288.02

mg/l

0.28

458

Maternal care for other known or suspected fetal problems

101

594

1.07

0.23

1.0

1.1

298.70

309.90

mg/l

0.94

548

Anomalies of dental arch relationship, including avohilmo

779

1.07

0.23

1.0

1.1

293.95

289.83

mg/l

0.19

722

Carbimazole or st.post thyroidectomy, condition for graves disease

785

1.07

0.23

1.0

304.68

293.68

mg/l

0.75

709

Other and unspecified disorders of vitreous body

167

1558

1.05

0.23

1.1

299.03

481.92

mg/l

0.48

144

1413

Disorders of refraction and accommodation

115

1211

0.95

0.22

1.0

1.1

274.03

289.01

mg/l

1.33

102

1112

Other disorders of bone density and structure

1.27

0.22

1.0

1.1

274.80

286.42

mg/l

—

Deep bite

406

0.91

0.22

1.0

1.1

286.56

293.07

mg/l

0.23

377

Prolapse and hernia of ovary and fallopian tube

1.24

0.22

1.0

338.00

300.52

mg/l

—

Universal erythroderma, KELA reimbursement

1.22

0.22

1.0

242.80

279.08

mg/l

—

Primary open-angle glaucoma, strict

719

0.93

0.22

1.0

287.32

292.59

mg/l

0.28

643

Sequelae of injuries of neck and trunk

107

1.22

0.21

1.2

1.1

319.31

278.59

mg/l

0.84

Dermatitis due to ingested food

120

1.20

0.21

1.0

1.1

273.20

290.46

mg/l

0.51

111

Asymmetry of jaw

1.19

0.21

1.0

1.1

276.80

291.22

mg/l

—

Adrenogenital disorders

0.00

0.21

0.0

1.1

—

279.73

—

Female infertility, uterine origin

0.00

0.21

0.0

1.0

—

293.70

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

0.00

0.21

0.0

1.0

—

263.64

—

Degenerative conditions of globe

0.00

0.21

0.0

1.1

—

272.10

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.21

0.0

1.0

—

267.18

—

Neonatal jaundice from other and unspecified causes

1.18

0.21

1.0

1.1

314.80

283.63

mg/l

—

Corneal scars and opacities

1.24

0.21

1.1

1.0

293.27

280.43

mg/l

0.19

Open wound of hip and thigh

123

0.81

0.20

1.1

262.50

274.79

mg/l

—

113

Primary angle-closure glaucoma

111

0.81

0.20

1.1

1.0

289.67

295.07

mg/l

—

Respiratory conditions due to other external agents

1.18

0.19

1.0

377.00

286.59

mg/l

—

Keratoconus

1.22

0.19

1.0

307.64

283.51

mg/l

0.57

Labour and delivery complicated by fetal stress [distress]

613

0.94

0.19

1.1

287.80

305.03

mg/l

1.30

568

Pedal cyclist injured in other and unspecified transport accidents

424

1.09

0.18

1.1

295.83

289.23

mg/l

0.23

389

Acute appendicitis, with complications

715

1.06

0.18

1.1

278.12

284.19

mg/l

0.34

658

Injury of muscle and tendon at ankle and foot level

100

1.20

0.18

1.0

1.1

261.25

284.41

mg/l

0.61

Burns and corrosions confined to eye and internal organs

100

1.20

0.18

1.1

249.14

277.51

mg/l

—

Sequelae of other external causes

185

1.14

0.18

1.1

296.43

289.02

mg/l

0.18

170

Complications of labour and delivery

265

1427

1.03

0.17

1.1

300.42

510.29

mg/l

0.51

245

1291

False labour

130

771

1.05

0.17

1.0

1.1

290.45

306.48

mg/l

1.56

124

712

Abrasion of teeth

157

1510

1.04

0.17

1.1

299.32

291.50

mg/l

0.68

143

1370

Disorders of optic nerve and visual pathways

329

1.10

0.17

1.0

296.47

291.81

mg/l

0.12

304

Postpartum haemorrhage due to retained placenta

474

1.08

0.17

1.0

1.1

303.96

298.79

mg/l

0.14

449

Malignant neoplasm of cervix uteri, including Hilmo

1.13

0.17

1.1

1.0

333.00

296.16

mg/l

—

Retinoschisis and retinal cysts

1.11

0.17

1.0

267.86

293.72

mg/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.76

0.17

1.0

1.1

270.20

271.62

mg/l

—

Aortic valve malfunction, age under 60 years

378

1.09

0.17

1.1

315.57

280.20

mg/l

1.66

353

Malignant neoplasm of brain, including Hilmo

148

1.15

0.17

1.1

294.71

281.44

mg/l

0.29

135

Disorders of breast

205

1746

1.03

0.16

1.1

299.19

472.04

mg/l

0.52

188

1577

Gonarthrosis [arthrosis of knee](FG)

324

1816

1.03

0.16

1.1

285.50

450.27

mg/l

0.52

282

1659

Pediculosis, acariasis and other infestations, including avohilmo

751

0.94

0.16

1.1

292.77

286.31

mg/l

0.38

695

Cardiac murmurs and other cardiac sounds

308

1.09

0.16

1.1

283.04

293.90

mg/l

0.27

284

Spontaneous abortion

189

1224

1.03

0.15

1.1

1844.24

299.89

mg/l

0.50

173

1107

Burns and corrosions of multiple and unspecified body regions

0.79

0.15

1.0

1.1

267.83

278.52

mg/l

—

Benign lipomatous neoplasm

112

1073

1.04

0.15

1.0

1.1

292.32

286.87

mg/l

0.34

100

978

Hyperaldosteronism

0.78

0.15

1.2

1.0

241.00

278.86

mg/l

—

malignant neoplasm of male genital organs

563

0.95

0.15

1.1

267.00

272.47

mg/l

0.34

520

Lesion of sciatic nerve

0.75

0.15

1.0

245.83

295.06

mg/l

—

Other specified and unspecified disorders of eye and adnexa

119

0.84

0.15

1.2

1.1

320.50

288.08

mg/l

—

106

Glucosamine medication

143

1184

0.96

0.15

1.1

300.05

294.57

mg/l

0.45

121

1058

Colorectal cancer

701

1.05

0.15

1.0

296.90

286.04

mg/l

0.68

636

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

207

1.11

0.15

1.0

1.1

296.78

279.37

mg/l

0.56

191

Thoracic aortic aneurysm

449

1.07

0.14

1.1

282.93

278.01

mg/l

0.20

415

Other disorders of eyelid

151

1474

0.97

0.14

1.1

285.93

295.23

mg/l

0.94

136

1331

Burn and corrosion of head and neck

0.79

0.14

1.0

1.1

363.57

279.10

mg/l

—

Seropositive rheumatoid arthritis, strict definition

502

0.94

0.14

1.0

283.48

292.34

mg/l

0.30

452

Pterygium

0.79

0.14

1.0

1.1

289.43

294.23

mg/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

275

1.09

0.14

1.0

292.04

291.24

mg/l

0.02

250

Coxarthrosis, primary

215

1834

0.97

0.14

1.1

294.42

452.16

mg/l

0.49

192

1655

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

587

1.06

0.14

1.1

1.0

296.09

286.60

mg/l

0.49

533

Malignant neoplasm of other connective and soft tissue, including Hilmo

122

1.15

0.13

1.1

1.0

315.43

290.26

mg/l

0.62

112

Maternal care related to the fetus and amniotic cavity and possible delivery problems

184

1110

0.97

0.13

1.0

1.1

303.13

304.41

mg/l

0.09

174

1006

Arthropod-borne viral fevers and viral haemorrhagic fevers

325

1.08

0.13

1.2

1.1

263.91

289.09

mg/l

1.32

300

Other noninflammatory disorders of uterus, except cervix

444

1.05

0.13

1.0

1.1

308.72

975.51

mg/l

0.50

398

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

159

0.88

0.13

1.1

1.0

276.57

297.20

mg/l

1.30

141

Disorders of eyelid in diseases classified elsewhere

1.17

0.13

1.1

275.27

286.61

mg/l

0.18

Scabies, including avohilmo

652

0.95

0.12

1.1

289.18

287.01

mg/l

0.09

605

Other and unspecified glaucoma

168

0.89

0.11

1.0

297.87

290.39

mg/l

0.20

150

Supervision of normal pregnancy

482

1.04

0.11

1.1

298.24

310.18

mg/l

0.87

450

Other and unspecified abdominal hernia

124

1.13

0.11

1.1

1.0

327.21

285.14

mg/l

1.25

110

Hallux rigidus

445

1.06

0.11

1.1

282.23

296.84

mg/l

0.91

405

Other specified disorders of muscle

1.16

0.11

1.1

262.10

277.81

mg/l

—

Malignant melanoma

465

1.05

0.11

1.1

1.0

293.39

287.00

mg/l

0.23

421

Adhesive middle ear disease

1.14

0.10

1.0

1.1

282.40

271.18

mg/l

—

Chronic suppurative otitis media

213

1.08

0.09

1.0

1.1

272.13

281.32

mg/l

0.23

192

Sacrococcygeal disorders, not elsewhere classified

1.14

0.09

1.1

309.55

294.78

mg/l

0.32

Hypothermia

1.07

0.08

1.2

1.1

212.33

278.86

mg/l

—

Sequelae of infectious and parasitic diseases, including avohilmo

253

1.07

0.08

1.0

1.1

290.85

282.04

mg/l

0.28

233

Carcinoma in situ of skin of upper limb, including shoulder

1.03

0.08

1.0

303.50

295.15

mg/l

—

HSIL lesion of the cervix uteri, vagina or vulva

765

0.97

0.08

1.1

311.52

299.50

mg/l

0.75

697

Maxillary retrognathism

0.83

0.08

1.2

1.1

251.60

290.85

mg/l

—

Bruxism

0.83

0.08

1.0

1.1

294.60

294.80

mg/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

154

0.91

0.08

1.0

1.1

324.44

285.63

mg/l

—

139

Exposure to other and unspecified man-made environmental factors

1.08

0.08

1.0

1.1

257.29

276.93

mg/l

—

Perioral dermatitis

1.08

0.08

1.1

303.14

302.64

mg/l

—

Other specified/unspecified spondylopathies

1.06

0.08

1.1

1.0

280.29

283.96

mg/l

—

Dissocial personality disorder

0.84

0.07

1.0

1.1

295.83

259.97

mg/l

—

Melanocytic naevi of upper limb, including shoulder

0.82

0.07

1.0

1.1

279.17

291.66

mg/l

—

Other specified/unspecified hearing loss

264

1.06

0.07

1.0

283.79

292.83

mg/l

0.31

241

Other obstetric trauma

176

1.08

0.07

1.0

1.1

320.79

299.19

mg/l

0.32

165

Glaucoma-related operations

143

0.91

0.07

1.0

302.08

291.07

mg/l

0.34

124

Other disorders of penis

372

1.05

0.07

1.0

1.1

278.29

272.39

mg/l

0.25

347

Problems related to social environment

1.03

0.07

1.1

33512.38

291.59

mg/l

—

Bacterial pneumonia, not elsewhere classified

134

1201

0.98

0.07

1.1

298.36

285.04

mg/l

1.19

129

1089

Injury of nerves and spinal cord at neck level

0.87

0.07

1.1

273.00

278.32

mg/l

—

Polycystic kidney disease

0.83

0.07

1.1

380.43

276.99

mg/l

—

Basal cell carcinoma

155

1077

0.98

0.07

1.1

1.0

302.91

287.59

mg/l

1.93

137

978

Exposure to smoke, fire and flames

0.89

0.06

1.0

1.1

295.13

278.04

mg/l

—

IgA nephropathy (IgA glomerulonephritis)

0.86

0.06

1.1

255.38

277.91

mg/l

—

Other, unspecified and serous retinal detachments

0.86

0.06

1.1

283.00

280.73

mg/l

—

Other and unspecified erythematous conditions

0.85

0.06

1.0

1.1

302.63

287.32

mg/l

—

Burn and corrosion of trunk

0.84

0.06

1.1

246.13

287.10

mg/l

—

Other and/or unspecified nontoxic goitre

224

0.94

0.06

1.0

294.19

300.51

mg/l

0.17

203

Persons with potential health hazards related to communicable diseases

170

1656

1.02

0.06

1.1

293.73

286.87

mg/l

0.42

157

1535

Toxic effect of contact with venomous animals

142

0.91

0.06

1.1

1.0

298.00

284.42

mg/l

0.42

128

Sequelae of infectious and parasitic diseases

246

1.06

0.06

1.0

1.1

288.42

281.38

mg/l

0.21

226

Other hammer toe(s) (acquired)

489

0.97

0.06

1.1

312.30

299.85

mg/l

0.59

439

Malignant neoplasm of brain

109

1.10

0.06

1.2

1.0

293.50

277.26

mg/l

0.26

104

Sequelae of other and unspecified infectious and parasitic diseases

207

1.06

0.06

1.0

1.1

294.18

279.37

mg/l

0.44

191

Recurrent dislocation and subluxation of joint

266

1.05

0.06

1.1

274.89

284.23

mg/l

0.25

240

Antepartum haemorrhage, not elsewhere classified

296

1.05

0.05

1.1

300.69

303.48

mg/l

0.07

270

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

306

1.05

0.05

1.1

279.91

283.45

mg/l

0.09

278

Hyperplasia of prostate

131

751

0.98

0.05

1.0

1.1

276.85

276.17

mg/l

0.04

117

698

Malignant neoplasm of skin, including Hilmo

206

1361

1.01

0.05

1.1

1.0

300.16

502.56

mg/l

0.46

186

1234

LeFortI or BSSO operation

151

0.93

0.05

1.0

1.1

268.29

286.75

mg/l

1.34

141

Hallux valgus (acquired)

123

893

0.98

0.04

1.1

1.0

304.17

627.66

mg/l

0.49

110

807

Artificial joint operation, meniscal resection

399

2569

0.99

0.04

1.1

282.58

403.60

mg/l

0.54

357

2348

Anogenital herpesviral [herpes simplex] infection, including avohilmo

423

0.97

0.04

1.1

1.0

301.57

294.03

mg/l

0.12

391

Malignant neoplasm of breast, HER-negative

620

1.02

0.04

1.1

1.0

314.95

298.14

mg/l

1.02

554

All dysplastic lesions of the cervix uteri

100

1000

0.98

0.04

1.1

306.19

301.23

mg/l

0.30

909

Blepharochalasis

986

0.98

0.04

1.0

1.1

288.25

295.32

mg/l

0.46

889

Schizophrenia

656

1.02

0.04

1.1

283.95

281.71

mg/l

0.09

608

Maternal care for known or suspected abnormality of pelvic organs

103

684

1.02

0.04

1.1

306.43

305.92

mg/l

0.02

628

Motorcycle rider injured in noncollision transport accidents

119

0.92

0.04

1.0

1.1

283.09

272.49

mg/l

0.20

110

Malignant melanoma, including Hilmo

542

0.98

0.03

1.1

1.0

293.94

289.02

mg/l

0.17

493

Laparoscopic right hemicolectomy

159

0.94

0.03

1.0

328.40

289.90

mg/l

0.72

139

Primary coxarthrosis, bilateral

853

0.98

0.03

1.1

291.87

292.82

mg/l

0.05

768

Tinnitus

877

1.01

0.03

1.1

286.46

289.89

mg/l

0.16

797

Bacterial pneumonia (organism specified)

156

1426

0.99

0.03

1.1

300.43

287.62

mg/l

1.24

148

1291

Other diseases of spinal cord

108

0.93

0.03

1.1

277.90

280.12

mg/l

—

Malignant neoplasm of eye, brain and central nervous system

142

1.06

0.02

1.1

309.20

283.20

mg/l

0.50

132

Maternal care for known or suspected disproportion

152

1.05

0.02

1.1

1.0

271.25

305.67

mg/l

0.97

137

Basal cell carcinoma, including Hilmo

165

1126

0.99

0.02

1.1

1.0

301.73

287.47

mg/l

1.80

147

1020

Periodontal disease, other/unspecified

1.08

0.02

1.0

1.1

314.20

292.98

mg/l

—

Other erythematous conditions

107

0.93

0.02

1.0

1.1

284.60

285.16

mg/l

—

Glaucoma suspect

123

1239

0.99

0.01

1.1

290.15

292.27

mg/l

0.13

115

1116

Malignant neoplasm of skin

191

1285

1.01

0.01

1.1

1.0

300.44

515.97

mg/l

0.46

170

1164

Bacterial pneumoniae

147

1298

0.99

0.01

1.1

297.67

285.78

mg/l

1.11

141

1176

Infective dermatitis

393

1.02

0.01

1.1

313.83

290.76

mg/l

0.58

358

Bilateral sagittal split ramus osteotomy operation

126

0.95

0.00

1.0

1.1

271.50

287.15

mg/l

0.96

118

Family history of certain disabilities and chronic diseases leading to disablement

176

0.97

0.00

1.2

1.1

279.76

293.56

mg/l

0.31

166

Poor fetal growth

434

1.01

0.00

1.0

1.1

282.11

300.88

mg/l

1.34

402

Mandibular retrognathia

245

0.98

0.00

1.0

1.1

290.33

291.34

mg/l

0.02

229

Maternal care for known or suspected malpresentation of fetus

525

1.00

0.00

1.1

309.35

308.17

mg/l

0.04

482

Female genital prolapse

542

1.00

0.00

1.0

1.1

289.06

851.54

mg/l

0.52

487

Malignant neoplasm of breast, ER-negative, including Hilmo

667

1.00

0.00

1.1

1.0

314.20

298.56

mg/l

1.02

597

Major anomalies of jaw size

1.04

0.00

1.1

284.90

281.84

mg/l

—

Hodgkin lymphoma, hilmo

104

0.96

0.00

1.2

1.1

329.10

279.00

mg/l

—

Polycystic ovarian syndrome, broad definition

383

0.99

0.00

1.1

296.18

302.72

mg/l

0.19

356

Viral haemorrhagic fevers, not elsewhere classified/unspecified

278

1.01

0.00

1.2

1.1

268.14

286.73

mg/l

0.67

258

Congenital ovarian cysts

138

1.01

0.00

1.0

275.57

305.50

mg/l

0.84

129

Fracture of forearm

241

2164

1.00

0.00

1.0

1.1

296.75

425.62

mg/l

0.47

224

1963

Other congenital malformations of face and neck

103

0.97

0.00

1.1

295.50

289.61

mg/l

—

Pneumonia due to other infectious organisms, not elsewhere classified

103

0.97

0.00

1.1

1.0

313.20

282.48

mg/l

—

Non-Hodgkin lymphoma, all

103

0.97

0.00

1.0

298.40

286.59

mg/l

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

211

1.00

0.00

1.1

1.0

303.14

289.85

mg/l

0.31

190

Dextrocardia

0.00

0.0

1.2

—

295.20

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

294.00

—

Thromboangiitis obliterans

0.00

0.0

1.1

—

261.00

—

Drug-induced gout

0.00

0.0

1.0

—

292.80

—

Osteogenesis imperfecta

0.00

0.0

1.2

—

282.83

—

Pectus carinatum, including avohilmo

0.00

0.0

1.0

—

294.17

—

Follicular keratosis (Darier-White)

0.00

0.0

1.1

—

287.14

—

Imperforate hymen

0.00

0.0

1.2

—

289.33

—

Injury of blood vessels of thorax

0.00

0.0

1.1

—

271.75

—

Exposure to sunlight

0.00

0.0

1.1

—

280.13

—

Inflammatory myopathy

0.00

0.0

1.0

—

259.20

—

Malignant neoplasm of other endocrine glands and related structures

0.00

-0.00

0.0

1.2

—

258.83

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

267.60

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.0

—

314.40

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

1.3

—

266.75

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

1.2

—

271.20

—

Malignant neoplasm of nasopharynx

0.00

-0.00

0.0

1.0

—

283.00

—

Pectus carinatum

0.00

-0.00

0.0

1.0

—

306.00

—

Other congenital malformations of respiratory system

0.00

-0.00

0.0

1.0

—

291.80

—

Patellar tendinitis

0.88

-0.00

1.2

1.1

298.33

279.25

mg/l

—

Follicular keratosis (Darier-White), including avohilmo

0.00

-0.00

0.0

1.1

—

287.14

—

Epiphora

1.02

-0.00

1.0

1.1

277.00

292.65

mg/l

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

0.00

-0.00

0.0

1.0

—

275.00

—

Kwashiorkor

0.00

-0.00

0.0

1.2

—

242.50

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.2

—

284.60

—

Toxic colitis

0.00

-0.00

0.0

1.2

—

306.17

—

Sexual dysfunction

0.90

-0.00

1.0

1.1

295.71

272.08

mg/l

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.2

—

239.60

—

1.00

-0.00

1.0

338.00

280.93

mg/l

—

Other sideroblastic anaemias

0.00

-0.00

0.0

1.1

—

284.75

—

Superficial injury of neck

0.87

-0.00

1.0

1.1

315.83

282.84

mg/l

—

Disorders of amino-acid transport

0.00

-0.00

0.0

1.2

—

315.20

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.1

—

275.71

—

Burn and corrosion of other internal organs

0.00

-0.00

0.0

1.0

—

280.67

—

Crushing injury of forearm

0.00

-0.00

0.0

1.0

—

256.60

—

Use of interferon beta-1a

0.89

-0.00

1.0

1.1

293.00

292.59

mg/l

—

Other lesions of median nerve

0.93

-0.00

1.0

294.00

287.94

mg/l

—

Peroneal tendinitis

0.88

-0.00

1.0

1.1

263.80

293.60

mg/l

—

Routine general health check-up of defined subpopulation

0.85

-0.00

1.2

1.1

324.20

297.04

mg/l

—

Exposure to electric transmission lines

0.00

-0.00

0.0

1.4

—

261.00

—

Exposure to noise

0.00

-0.00

0.0

1.0

—

276.00

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.2

—

280.83

—

Inguinal hernia, unilateral

0.93

-0.00

1.0

1.1

320.57

281.70

mg/l

—

Assault by unspecified chemical or noxious substance

0.00

-0.00

0.0

1.2

—

270.80

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

1.0

—

289.20

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.0

—

289.67

—

Femoral hernia, unilateral

0.93

-0.00

1.0

1.1

320.57

281.70

mg/l

—

Contact with lifting and transmission devices, not elsewhere classified

0.96

-0.00

1.0

1.1

274.00

270.49

mg/l

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.0

—

250.67

—

Intentional self-harm by other and unspecified firearm discharge

0.00

-0.00

0.0

1.0

—

274.33

—

Inguinal of femoral hernia, unilateral

0.93

-0.00

1.0

1.1

320.57

281.70

mg/l

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

-0.00

0.0

1.0

—

295.43

—

Leptospirosis, including avohilmo

0.00

-0.00

0.0

1.0

—

288.00

—

Excessive and redundant skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

312.40

—

Leptospirosis

0.00

-0.00

0.0

1.0

—

288.00

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

-0.00

0.0

1.0

—

264.20

—

Other and unspecified disorders of globe

0.00

-0.00

0.0

1.2

—

255.60

—

Mandibular retrognathia AND surgery (BSSO)

0.92

-0.00

1.0

1.1

274.25

284.63

mg/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.3

—

270.17

—

Malignant neoplasm of oropharyng

0.00

-0.00

0.0

1.0

—

249.60

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.87

-0.00

1.0

321.50

282.05

mg/l

—

Ebstein's anomaly

0.00

-0.00

0.0

1.1

—

287.86

—

Suppurative otitis media, unspecified

0.97

-0.00

1.0

1.1

279.14

282.91

mg/l

—

Noonan syndrome

0.00

-0.00

0.0

1.4

—

280.00

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ceruloplasmin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS